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Laburpena  
Biomaterialek funtsezko eginkizunak betetzen dituzte nanozientziaren 
esparruan, prozesu biologikoetan parte hartzen duten molekulek eta bio-
egiturek eskala nanometrikoa dutelako. Beraz, ez da harritzekoa 
nanozientziatik abiatutako biomaterialak erabiltzea konposatu berrien 
ingenieritzan zein funtzionalitate berriak helburu dituzten ikerketetan. 
Entzimen imitazioa susperraldian dagoen ikerketa lerroa da biologian 
inspiratutako nanozientzian. Honek material berriak aztertzea du helburu, 
batez ere entzimen katalizatzaile funtzioa imitatu edo simulatu dezaketeenak. 
Entzimak oso eraginkorrak dira ingurune biokimikoetan, baina industria 
produkzioa bezalako prozesu exijenteetan alternatiba egonkor eta 
eraginkorrak behar dira. Zentzu horretan nanopartikula inorganikoen eta 
proteinen arteko bateraketatik sortutako konposatu hibridoek eraldaketa 
katalitikorako beharrak bete ditzakete. 
Ferritina naturan kopuru handitan eskuragarri dagoen nanometroen eskalako 
biomateriala da. Berau zeluletako burdinaren metabolismoko funtsezko 
proteina bat da eta bi funtzio nagusi ditu: burdina garraiatzea eta burdina 
gorde eta metatzea. Ferritina proteinak 24 azpiunitatez osatutako esfera 
forma du; kanpo diametroak 12 nm dituelarik eta barruan 8 nm-ko barrunbe 
hutsa duelarik. Naturan barrunbe hau burdina gordetzeko erabiltzen da, 
ferrihidrita mineral moduan. Burdinarik gabeko ferritinaren kapsulari 
apoferritina deritzo. Giza apoferritina bi azpiunitate ezberdinez osaturik dago, 
funtzionalitate bereiztuekin: H-katea (ingelesezko heavy chain) proteinak 
ferroxidasa aktibitatea du; L-katea (ingelesez light chain) proteinak aldiz, 
burdinaren nukleazioan lagundu eta mineralizazioa errazten du. 
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Apoferritinaren egitura nanozientziako zenbait aplikaziotan erabiltzeko 
aztertua izan da; horien artean dira sendagaien askatze kontrolatua, entzimen 
imitazioa edo nanopartikulen sintesia. 
Ferritina oinarri duten nanokonposatuak sortzeko bi bide nagusi daude (I. 
irudia); batetik metalezko nanopartikulak osatzeko erabiltzen dena, inkubazio 
zuzena deritzona. Metal ioiak apoferritinaren barnera sartzen dira inkubazioan 
zehar, eta proteinaren purifikazioaren ondoren, apoferritina barnean 
gelditutako ioiak erreduzituz partikulak osatzen dira. Bestetik, bigarren 
metodoa aurrez sortutako nanopartikulak edo sendagaiak enkapsulatzeko 
erabiltzen da. Teknika hau pH-aren aldaketan oinarritzen da. pH 2-an ferritina 
desegituratu egiten da eta une horretan enkapsulatu nahi den 
konposatuarekin kontaktuan jartzen da. Azkenik, pH-a 7-8 ra igoz ferritinak 
bere oinarrizko egitura hartzen du, barruan partikula-zein sendagaiak 
harrapatuz. 
 
 
I. irudia. Enkapsulaziorako bi prozesuren irudi eskematikoa. 1. Metodoa: metal ioien 
eta apoferritinaren arteko inkubazio zuzen bidezko sintesia. 2. Metodoa: pH-aren 
aldaketak eragindako proteinaren desegite eta berregituraketaren bidezko sintesia.  
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Orokorrean, sortutako nanokonposatu berri hauen funtzionalitatea ferritina 
barruan dagoen konposatuak emandakoa izango da. Era honetan, 
erresonantzia magnetiko bidezko irudigintzan erabiltzen diren manganeso 
edo gadoliniozko kontraste agenteak sortu daitezke edo doxorrubicina edo 
cisplatin bezalako minbiziaren kontrako sendagaiak enkapsulatu. 
Tesi honetan ferritina naturala eta sintetikoa hiru ikuspuntu ezberdinetatik 
aztertu dira. Lehenengo, ferritina barruan sintetizatutako nanopartikulen 
aktibitate katalitikoa ikertu da. Gero, enkapsulatutako platinozko 
nanopartikulen ferroxidasa aktibitate bioinorganikoa eta biomineralizazioan 
duten eragina aztertu da. Azkenik, ferritina proteinaren propietate 
intrintsekoak ikertu dira, horretarako redox erreakzio bat erabiliz. 
Hasteko, apoferritina barruan sintetizatutako platinozko nanopartikulen (Pt-
apo) aktibitate katalitikoa karakterizatu da, arreta berezia jarriz katalasa eta 
superoxido dismutasa (SOD) entzimen aktibitatearen imitazioan. Aurretik 
nanokonposatuak erakutsitako aktibitateak, 3-amino-1,2,4-triazole (3AT), 
NaN3 (A inhibitzailea) eta Hg2+ inhibitzaileak erabiliz nola aldatzen diren 
aztertu da. 3AT inhibitzaileak (B inhibitzailea) bi erreakzioak inhibitzeko 
gaitasuna erakutsi du, NaN3-ak berriz soilik katalasa inhibitzekoa. Era 
honetan modu selektiboan bi erreakzioetako baten inhibizioa lortu da bestea 
aktibo mantentzen den bitartean. Azkenik, erredukzio agenteen bidez, 
nanopartikulen gainazalaren egitura kimiko eta funtzionala itzulkorra eta 
iraunkorra dela frogatu da (II. irudia).  
Bestetik, apoferritina barruan sintetizatuko urrezko nanopartikulen (Au-apo) 
eta merkurio ioien (Hg2+) arteko elkarrekintza karakterizatu da. Bi 
konposatuen elkarrekintzaren ondorioz, katalasaren imitazioan inaktiboa zen 
urrea aktibatzea lortu da. Ondoren, urrearen gain izandako eragina hobeto 
aztertzeko urrezko nanopartikulak erabili dira antzeko aktibazioa ikusiz. 
Behaketa garrantzitsu hau ingelesezko sputter teknikaren bidez jarritako 
urrezko gainazal mehekin esperimentatuz karakterizatu da. Urrezko 
nanopartikula eta gainazaletan aztertutakoa erabiliz, erreakzio mekanismo bat 
proposatu da. 
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II. irudia. Pt-apo konposatuaren aktibitate katalitikoa eta honen inhibizioa 
irudikatzeko erabilitako eskema.  
 
Aurretiko bi entzimen imitazioaz gain, enkapsulatutako platinozko 
nanopartikulen ferroxidasa aktibitate bioinorganikoa ikertu da. Ferroxidasa 
aktibitaterik gabeko L-kateez osatutako apoferritina homopolimerikoetan 
sintetizatutako platinozko nanopartikulek ferroxidasa aktibitatea izatea lortzen 
du. Aktibitate hau platinozko nanopartikuletatik datorren arren, ferritina 
naturala bailitzan burdina mineralizatzea lortu da.  
Ferritinaren proteinetan arreta jarriz, L-kate proteinikoaren ezaugarri 
intrintseko bat identifikatu eta karakterizatu da, redox erreakzio bat erabiliz. 
Ferritinaren barruan gertatzen den burdinaren oxidazioa, ferritinaren kanpoan 
gertatzen den zitokromo c-ren erredukzioarekin lotzea lortu da. L-kateak ez 
du inolako ferroxidasa aktibitaterik eta beraz ezin du burdina oxidatu; bestetik, 
H-kate proteinikoak ferroxidasa aktibitatea duen arren, ezin du zitokromo c 
erreduzitu. L- eta H- kateez osatutako ferritinak soilik izan du zitokromo c-ren 
erredukzio eraginkorrerako gaitasuna. Azkenik, L-kateak elektroiak eroateko 
duen gaitasuna bi norantzatan doala frogatu da (III. irudia). Aurkikuntza berri 
honek ferritinaren inguruan aurrerantzean egingo diren ikerketa 
biokimikoetarako garrantzi berezia izango du. 
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III. irudia. L-kate proteinikoaren ezaugarri intrintseko bat identifikatzeko egindako 
erreakzioen irudi eskematikoa. 
 
Bukatzeko, uhin luzeera ezberdinetako LED argiak erabiliz, ferritinaren 
mineralaren desmineralizazioa aztertu da. Kasu honetan, energetikoena den 
argi urdinak soilik lortu du ferritina barruan ferrihidrita minerala 
desmineralizatzea. Zelularen metabolismorako burdina funtsezko elementua 
dela jakinda, argi urdinaz irradiatutako zelulen bideragarritasunean izandako 
jaitsiera desmineralizazio honen ondorioz izan daitekeela proposatu da. 
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Abstract 
Biomaterials play a crucial role in nanoscience, not at least because many 
processes in biology involve molecules and assemblies on the nanometre 
scale. Therefore it is not astonishing that numerous approaches in 
nanoscience make use of biomaterials with the aim to engineer novel 
composites with novel or improved functionalities.  
One emerging research direction in bio-inspired nanoscience is enzyme 
mimetics, which studies materials that are able to imitate or simulate the 
catalytic functionality of enzymes. Even though enzymes are very efficient in a 
biochemical environment, high-throughput processes, such as industrial 
production, have a higher demand on efficiency and stability and therefore 
alternative materials will be appreciated. A combination of inorganic 
nanomaterials with proteins may be a pathway to satisfy this demand in case 
these new hybrid materials can fulfil the needs of catalytic conversion. 
One biomaterial on the nanoscale, which is naturally available in great 
amounts, is ferritin. It is a protein essential for the iron metabolism of cells and 
acts as iron transport and storage unit. The protein is a spherical assembly of 
24 subunits with an outer diameter of 12 nm and an internal cavity of around 
8 nm. This cavity is naturally used for storage of iron in form of ferrihydrite. 
The ferritin capsule without embedded iron is called apoferritin. Human 
apoferritin may consist of two different types of subunits with different 
functionalities, the heavy chain (H-chain) protein with ferroxidase activity and 
the light chain (L-chain) protein that promotes the nucleation of iron and the 
mineral formation. 
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Apoferritin has been studied for various applications in nanoscience, including 
drug delivery, enzyme mimetics or as template for nanoparticle growth. 
In this thesis natural and synthetic hybrid ferritin are studied from three 
different perspectives:  
On the one hand the catalytic activity of platinum nanoparticle-apoferritin 
nanocomposites (Pt-apo) is characterized with specific focus on the activities 
mimicking catalase and superoxide dismutase (SOD). The possibility of tuning 
the activities with a variety of inhibitors and the possibility to selectively inhibit 
one of the two reactions are investigated.  
On the other hand the interaction of gold nanoparticles encapsulated within 
apoferritin (Au-apo) with mercury ions (Hg2+) is characterized. Here, a very 
interesting observation is that such interaction activates the catalase 
mimicking activity of gold, which without mercury is not present. Based on 
experiments on thin gold films, a mechanism for the catalytic reaction is 
proposed.  
As a further enzyme mimicking reaction, the bioinorganic ferroxidase activity 
of encapsulated platinum nanoparticles is studied. After encapsulation of 
platinum nanoparticles specifically within homopolymeric L-chain apoferritin, 
the resulting hybrid nanoparticle gains ferroxidase activity and becomes able 
to mineralize iron in a similar way natural ferritin does.  
With view on the ferritin protein, a new intrinsic property of the ferritin L-chain 
protein is identified and characterized. By separating the redox reaction of iron 
oxidation and reduction of Cytochrome C (Cyt-c) with either of the two H-chain 
or L-chain proteins, it was identified that only the L-chain assembly allows for 
an efficient reduction of Cyt-c and in consequence conduction of electrons. 
This new finding is considered being of importance for future investigations of 
biochemical processes in nature that involve ferritin. 
Finally, the demineralization of the ferritin mineral induced by illumination with 
light with various wavelengths is characterized. Here, it was identified that the 
highly energetic blue light can promote demineralization of the ferrihydrite 
inside ferritin. With iron being essential for the cellular metabolism, the 
Abstract 
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demineralization effect may serve as explanation for the viability decrease in 
cell cultures once those are exposed to blue light.  
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Chapter 1 
Introduction 
1.1. Bio-inspired nanotechnology 
Biomimetic research imitates and simulates the main principles from nature 1. 
The objectives of such research are to create new knowledge for engineering 
new materials, which will offer new solutions for industry in response to 
environmental issues or medication 2–4. Such research witnesses rapid 
development over the past decades, promising a bright future for both 
systematics and materials 5.  
The characterization of biomaterials and their modification are key issues for 
any bio-inspired research 6. With this respect, protein based compounds or 
natural hybrid materials are in the focus of most of those studies 7,8. Proteins, 
lipids, nucleic acids or carbohydrates are among those bio-compounds that 
can be further engineered in order to tune their functionality or even introduce 
new functionalities. In principle, most biomaterials can be termed 
nanomaterials due to their size, since the definition of nanomaterials refers to 
at least one dimension being below 100 nm 9.  
Nanoscience and nanotechology emerged from scientific contributions of 
several disciplines including, engineering, physics, biology, chemistry and 
materials science. The main prospect of such research is to gain access to 
physical or chemical properties of nanomaterials, which are different than the 
properties of the same material in its macroscopic shape or in bulk. Herein, 
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biomaterials play an important role for their complex functionalities and great 
application potential.  
The chemistry of each biomolecule has an enormous impact on its 
functionality. In bio-based nanoscience researchers further adapt the 
functionalities of biomolecules for certain target applications. Most important 
examples include: 
• Lipids. They have an amphiphilic nature and are able to self-
assemble. In nature they form cell membranes or membranes 
for further organelles or sub-cellular structures, like 
mitochondria or nuclei. In the past decades, natural assembly 
principles were adapted and various types of liposomes and 
carriers for drug delivery were developed 10 (Figure 1.1 A and 
Figure 1.1 B).  
• Proteins. Those are polypeptide chains that perform functions 
crucial for life, for example transport or catalysis. Catalytically 
active proteins are named enzymes. Modifications of proteins 
allow for their use as carriers in drug delivery systems 7,11,12 or 
as alternative and improved enzyme substitutes, termed 
enzyme mimics 13 (Figure 1.1 C and Figure 1.1 D).  
• Sugars or carbohydrates are typically parts of larger 
constructs, namely biopolymers named polysaccharides. In 
nature they often bind to proteins and in this way become 
constituting parts of glycoproteins. Often, they are involved in 
signalling. Technologically they are used to modify the surface 
of diverse nanomaterials for changing their wetting properties, 
or to modify the surface chemistry of a material, adding 
functionalities to bind further molecules 14 or particles 15 
(Figure 1.1 E and Figure 1.1 F). 
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• Nucleic acids are biopolymers formed by nucleotides, which 
consist of three components: sugars, phosphate groups and 
nitrogenous bases. The main function of those biomolecules is 
to encode and store information about the construction and 
composition of any cell of any life form. Designing of sequences 
of nucleotides nowadays enables constructions of three-
dimensional nano-scale structures 16 or a variety of approaches 
towards devices for disease detection 17,18 (Figure 1.1 G and 
Figure 1.1 H).  
 
The functionality of biomolecules is essential for life. Very often the 
functionality of biomolecules is linked to metals 19. Typical examples include 
oxygen transport by the iron in haemoglobin 20, control of the ionic and 
osmotic pressure of cells by sodium ions 21, etc. The metal ion usually does 
not act in its free form. In most of the cases it is bound to organic compounds 
to form cofactors for proteins.  
The fraction of metals compared to the organic fraction in such cases is very 
low. Nevertheless the combination of both adds great value to the functionality 
of the material, which encouraged numerous researchers to mimick such 
materials and to study new functional biocomposites 22. 
With regard to those research trends, the present thesis is built upon two main 
pillars. On one hand, metal-protein (ferritin) compositions are investigated for 
their catalytic functionalities and on the other hand, the biomolecule, more 
specifically the ferritin protein, is screened for its functionalities beyond the 
ones known from literature.  
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Figure 1.1. Biomaterials used in various applications in nanoscience. A) Lipids in 3 
different sizes and shapes 23. B) Functionalized liposome 24. C) Carbohydrate 
chain 25. D) Carbohydrate cage 26, 27. E) Protein 28. F) Protein covering a 
nanoparticle 29. G)	   Deoxyribonucleic acid (DNA) sequences 30. H) Immobilized 
DNA 31. 
 
Chapter 1 Introduction	  
	   5 
1.2. Proteins: (apo)ferritin 
Within the large group of organic biomolecules, proteins fulfil a very important 
role in any biochemical process. The structure and composition of proteins is 
very specific for the function they are supposed to have. Before going into 
detail with the functions or applicability of proteins, their structure or 
composition should be defined first 32.  
Proteins are biopolymers that are composed of monomeric units called amino 
acids. In eukaryotic organisms 20 different natural amino acids were 
identified. Amino acids are organic molecules with terminal amine (–NH2) and 
carboxylic (-COOH) groups, a functional group R that differentiates the amino 
acids form each other and defines its chemical properties. The molecular 
fraction R can be -CH2 in Glycine, or a substituted –CHR with more complex 
organics such as a variety of polar or non-polar, charged or uncharged 
substituents in the further 19 amino acids (Figure 1.2 A).  
For proteins four hierarchical levels of structuring are identified. The primary 
structure is reflected in the sequence of amino acids. Conventionally, the 
sequence is described with abbreviated letters representing each of amino 
acid, starting from the N-terminal group and ending with the C-terminal group. 
The chemical bond between the amino acids is called peptide bond and is 
formed between the carboxylic acid group of one amino acid and the amine 
group of another one (Figure 1.2 B and Figure 1.2 C).  
The secondary structure is given by the conformation the protein chain forms. 
It is resulting from intramolecular interactions between amino acids. Two 
types of structures are common, α-helixes (Figure 1.2 D) and the β-sheets 
(Figure 1.2 E), which are arranged and stabilized by folding of the proteins 
and formation of H-bonds between amino acids in proximity to each other. 
The tertiary structure is formed by formation of additional H-bonds, disulphide 
bridges or ionic interactions within the same protein chain and comprises the 
third dimensionality to a protein (Figure 1.2 F). 
 
Chapter 1 Introduction 
 6	  
 
 
 
 
Figure 1.2. Hierarchical levels of the protein structure. A) General structure of an 
amino acid. B) Peptide bond. C) Primary structure: Amino acid sequence. D) 
Secondary structure: α-helix. E) Secondary structure: β-sheet. F) Tertiary structure of 
the protein 28. G) Quaternary structure: assembly of proteins. 
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In the last hierarchical level, several protein chains or multiple folded protein 
subunits can assemble to form protein aggregates with more complex three-
dimensional structures. This last level is called the quaternary structure 
(Figure 1.2 G).  
As mentioned above, proteins fulfil a variety of functions including catalysis, 
signalling, transport or storage of materials 33. Ferritin is one of such proteins 
responsible for storage and transport of iron and will be described in more 
detail.  
Ferritin is a spherical protein that is ubiquitous in any kind of life 34. It is 
composed of 24 self-assembled subunits. The amino acid sequence of the 
subunits varies for different organisms, but they maintain a homology in the 
secondary, tertiary and quaternary structure.  
The assembled 24 proteins are forming a spherical structure with an outer 
diameter of 12 nm and an inner cavity of around 8 nm 35, which can store iron 
in form of the mineral ferrihydrite. The empty protein sphere is called 
apoferritin, while the iron-containing sphere is called ferritin. Specifically the 
human apoferritin protein cage is formed by two slightly differing types of 
subunits, the heavy chain (H-chain) and the light chain (L-chain) proteins 36. 
The ratio of the two subunits within the sphere depends on the organs where 
the ferritin is located (Table 1.1).  
 
Table 1.1. Percentage of the H- and L-chain subunits within ferritin from 
various tissues 37. 
Ferritin 
location 
Horse 
spleen 
Human 
spleen 
Human 
liver 
Human 
heart 
Human 
serum 
H-chain 8 10 50 90 0 
L-chain 92 90 50 10 100 
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The sequence homology within the two proteins is around 55 % and the main 
difference applies to outer and inner surfaces and their functional 
applicability 38. At the touching points of the subunits in the apoferritin sphere, 
characteristic channels are formed. Eight of those are hydrophilic and are 
located in the threefold symmetry axes. Further six hydrophobic channels are 
located in the fourfold symmetry axes 39,40. 
The two subunits have some functional differences. The most significant 
difference is that the H-chain protein can bind to two Fe2+ ions and catalyze 
their oxidation to Fe3+, which is subsequently stored as ferrihydrite inside the 
protein sphere 39,41. This ferroxidase active site is present in H-chain protein, 
but not in the L-chain protein. In contrast, the L-chain protein induces the 
formation of ferrihydrite having a specific nucleation site for the mineral 42. 
The iron mineralization process is necessary for effective iron storage inside 
ferritin and is a critical step in the iron metabolism. 
1.3. Iron, iron metabolism and Ferritin 
Iron is essential for most living organisms and cells 43, enabling oxygen 
transport, catalysis or DNA synthesis 44. Due to its versatile coordination 
chemistry and redox activity, iron contributes in various ways to biochemical 
processes. 
In excess, however, iron becomes potentially hazardous for cells. It catalyzes 
the formation of reactive oxygen species (ROS) via the Fenton reaction 45 
(Equation 1.1.), which then induce oxidative stress on cells 45. In the 
metabolism, iron appears in two distinct oxidation stages, the ferric iron (Fe3+), 
which is less reactive and more stable, but at the same time not soluble and 
difficult to be absorbed, and the ferrous iron (Fe2+), which is soluble, but more 
reactive 46. This makes the iron acquisition, use and release a very complex 
biochemical process 47.  
Equation 3.1: Fenton reaction 
 (1)   Fe2+  +  H2O2  →  Fe3+  + OH-  + OH· 
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The iron metabolism in the cells has been intensively studied for decades 48. 
The individual steps from the dietary uptake to the utilization in various cellular 
processes have been investigated in depth, but still the mechanism for many 
processes is not fully resolved 49. Generally, two types of cells should be 
distinguished in the iron metabolism; cells that uptake iron from intestinal 
lumen in the duodenum 46 (first part of the intestine in which iron is directly 
absorbed) and cells that uptake iron through transferrin 50. In both of those 
cases, specific facilitating proteins or organelles are needed. Following 
proteins or organelles are involved in the iron metabolism:  
• Transferrin (Trf) is a serum glycoprotein with 80 kDa molecular 
weight and two specific sites for ferric ion binding. Its main role 
is to first bind the iron in the vicinity of the cells in the duodenum 
or red blood cell recycling macrophage and to transport the iron 
to tissues with extensively dividing cells or any other cells in 
need of iron 51–53. 
• Transferrin receptor is formed by two monomers of 760 amino 
acids each. It is located in the cell membrane and has an 
intracellular region, a transmembrane domain (the brighter part 
in the representation Figure 1.3) and an extracellular part. Its 
main function is to bind the Trf, with each monomer of the 
extracellular glycosylated part being able to bind one Trf. Once 
bound, the iron will be internalized by endocytosis. In a similar 
way as Trf, ferritin proteins can also bind to the receptor and 
become internalized 52–54.  
• Ferroportins are proteins located in the cell membrane and are 
part of the family of transmenbrane proteins. Their main function 
is to transport iron from the inside to the outside of a cell. They 
play an essential role in duodenal cells being able to release 
iron, to reduce the internal iron release and to make iron 
available for its distribution to other cells by Trf 55,56.  
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• Ferritin is a protein constituted by 24 subunits. Its main function 
is to store iron. It is able to oxidize iron, to internalize it into cells 
and reduce the generation of ROS that are generated by the 
excess of the intracellular iron reacting with H2O2 via the Fenton 
reaction 34. 
• Mitochondrion is an organelle that acts as energy supplier for 
the cells. It is responsible for the formation of haeme 
cofactors 57. 
 
Figure 1.3. Simplified schematic overview of the iron metabolism within a cell. 
 
The iron metabolism is illustrated in Figure 1.3 in a simplified form. In this 
metabolism ferritin requires an effective biomineralization process to store the 
excess of iron inside the apoferritin in form of the ferrihydrite 58.  
1.3.1 Ferritin Biomineralization 
The mineralization process consists of two mains steps. Initially, Fe(II) enters 
the ferritin. Once inside, the oxidation and nucleation of iron occur and the 
ferrihydrite nanoparticle is formed 59. 
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The most likely pathway for the uptake of iron by the ferritin is diffusion 
through the channels at the 3-fold symmetry axes. Those channels are 
hydrophilic and possess some specific amino acids with carboxylated 
residues 60, which form a charge gradient to allow transport of iron ions 61,62. 
Inside the protein, the Fe2+ ions will become oxidized 63 and nucleation of the 
ferrihydrite will occur. Two ways have been identified for this process. 
• Iron will be oxidized by oxygen at the H-chain ferroxidase site. 
The resulting Fe3+ will migrate to the nucleation sites at the L-
chain subunits to nucleate and precipitate 63–65. 
• The other pathway involves the surface of the mineral core. In 
this process both the oxidation and the nucleation will take 
place at the surface of the ferrihydrite mineral. This process is 
faster than the previous, but requires an initial formation of the 
mineral 66. 
1.3.2 Demineralization 
The iron within the protein is stored as a particle, but the cells cannot use the 
iron-containing mineral directly. To make the iron available, a process reverse 
to the biomineralization, the demineralization process, is required. Fe3+ is 
highly insoluble, thus a reduction to Fe2+ is required before the release 67. This 
iron reduction occurs at the surface of the mineral core and the reduced iron 
is released upon chelation. This method is proposed and well described in the 
review article of R. Watt et al 67.  
The demineralization process can vary depending on the environmental 
conditions. Also external factors can influence the demineralization process, 
for example, ultraviolet light or ionizing laser pulses can be used for iron 
reduction and demineralization 12,67. 
1.4. Ferritin in nanoscience 
Besides the described biological functions of storage and transport of iron, 
ferritin can also be used for many other purposes 68,69. The inner cavity of 
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8 nm in diameter, the permeation channels and its ability to be disassembled 
and reassembled simply by varying the pH make ferritin an excellent tool for 
many investigations in nanoscience 70,71. Ferritin is equally suitable as 
template for nanoparticle synthesis and as carrier for controlled drug delivery. 
There are two common routes for the synthesis of ferritin-encapsulated 
compounds, either through direct incubation or through pH-mediated 
disassembly and reassembly. 
The direct incubation technique is inspired by the iron biomineralization 
process within the ferritin 72, where apoferritin is incubated with metal salt 
solutions. In a similar way to the natural process, the metal is internalized 
through the hydrophilic channels. Typically, the metal ions inside the 
apoferritin require an additional reducing agent like NaBH4 or H2 to nucleate 
and form a nanoparticle. The reaction conditions define the composition of the 
nanoparticle being either a metal 73,74, metal oxide 75 or further compounds 
like sulphides 76, etc (Figure 1.4 Method 1). 
 
 
Figure 1.4. Schematic representation of the two possible encapsulation processes. 
Method 1: direct incubation of apoferritin with metal ions. Method 2: disassembly and 
reassembly mediated by changing the pH.  
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This first method is only applicable with ions and particles that are small 
enough to enter the protein through the available channels. 
For larger particles or complexes the second method needs to be applied. 
Here, at pH 2 the quaternary structure of ferritin is first disassembled without 
denaturation of the protein. Then the material to be encapsulated is mixed 
with the protein-containing solution and finally, by increasing the pH to 
physiological values, the protein is reassembled. In this way a fraction of the 
material will be encapsulated 37,77. Due to the change in pH many pH sensitive 
compounds cannot be synthetized in this way. Nevertheless the process was 
shown to be effective for encapsulation of numerous drugs or nanoparticles 
(Figure 1.4 Method 2). 
1.4.1 Applications of ferritin based hybrid compounds 
Most of the developed composites target applications in the biomedical field. 
In most of the cases the specific functionality of each nanoparticle or molecule 
will define the functionality of the whole compound. Before further detailing on 
the applications of the synthetized ferritin based compounds, several 
attributes common for all the compounds should be mentioned. Generally, the 
biomolecules complement properties which inorganic nanoparticles usually 
don`t have. The most important property for bio-related research is 
biocompatibility. 
Once the nanoparticle is inside the protein shell of apoferritin, the 
biocompatibility of the nanoparticle increases considerably 78,79. This is 
resulting from the increased water solubility, the reduced cytotoxicity of the 
compound and the biological functionality given by the encapsulating protein.  
The latter point leads to the possibility of any encapsulated material to 
become internalized by receptor-mediated endocytosis 80–82. This process has 
been widely studied, resulting in the identification of various receptors for H- 
or L-ferritins on different cell types 77. 
These factors make ferritin a particularly suitable candidate for drug 
delivery 83 applications or gene therapy 84. In those cases the ferritin cavity 
can be loaded with an anticancer drug or a designed nucleic acid and 
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internalized. The ferritin capsule protects the sensitive molecules and 
prevents them from degradation or modification in a cellular environment. 
Furthermore, an internalization with H-chain ferritin into nuclei of cells has 
been recently demonstrated 77,84.  
Besides targeting therapies, many compounds are designed for a use in 
diagnosis. Classical clinical imaging techniques such as Magnetic Resonance 
Imaging (MRI) can be improved with specific contrasting agents 85,86, for 
example Gd (III)-complexes encapsulated with apoferritin 87. Also, 
nanoparticles of certain iron or manganese oxides have been studied as 
contrasting agents for MRI after encapsulation with apoferritin 88. 
Another area of application of ferritin-derived composites relates to 
catalysis 89–91. Apoferritin provides an excellent template for the size 
controlled synthesis of catalytic metallic nanoparticles 92. The outer protein 
further helps to solubilize the particles making an application of the catalysts 
in aqueous environment easier.  
Such composites can sometimes mimic specific catalytic reactions of 
enzymes. The catalytic activity is given by the corresponding properties of the 
metal inside apoferritin 93,94. Earlier works done in our group have shown that 
intracellular ROS levels could be decreased using hybrid nanocomposites 
based on ferritin 95. 
1.5. Present work 
This thesis has three main sections, with the common element for all of them 
being ferritin or apoferritin. The perspective to approach the ferritin activity 
was different in each individual part. Figure 1.5 outlines the cross-disciplinary 
nature of the thesis.  
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Figure 1.5. Topical spread and interdisciplinary nature of the thesis. 
 
In the first part (Chapter 3), the catalytic activity of metallic (Pt and Au) 
nanoparticles encapsulated within apoferritin is evaluated. In this part the 
ferritin acts as template for the metal nanoparticle synthesis only.  
In the second part (Chapter 4) the ferroxidase-mimicking activity of apoferritin 
encapsulated platinum is matter of in vitro studies with cell cultures. For that 
purpose, the biocompatibility and the ability of the ferritin to be internalized 
into the cells is of crucial importance.  
In the third part (Chapter 5) some intrinsic properties of the ferritin protein are 
evaluated in more detail. Our specific interests relate to the functional 
differences between L-chain and H-chain proteins.  
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Chapter 2 
Materials and Methods 
2.1 Materials and instruments 
Most of the proteins and chemicals in this thesis were purchased from Sigma 
Aldrich (Spain). Some specific proteins or specialized chemicals were 
purchased from other companies as indicated where they were mentioned; 
the specific and recombinant human heavy-chain ferritin (huFH), human light-
chain ferritin (huFL), human heavy-chain apoferritin (apo-huFH) and human 
light-chain apoferritin (apo-huFL) were purchased from MoLiRom (Italy). Most 
of the kits for bio-characterization, like Pierce® 660 nm Protein Assay Kit, 
Bradford Reagent and Cell Counting Kit 8 (CCK 8) were purchased from 
Thermo Scientific (Spain). 
Ultraviolet-visible (UV-Vis) absorption spectra were measured with a 
NanoDrop 2000c spectrometer (Thermo Scientific).  Platinum determination 
was done with atomic absorption spectroscopy (AAS) by the company 
BioSolutions (Halle, Germany). Electron microscopy was done with a TEM 
(Titan G2 60-300 operating at 80 KeV) and a SEM (FEI, Quanta 250 FEG). 
Further used instruments will be specified where those were used. 
Chapter 2 Materials and Methods 
 18	  
2.2 Synthesis and sample preparation 
2.2.1 Metal Nanoparticles within Apoferritin 
Platinum or gold nanoparticles encapsulated within apoferritin (Pt-apo and Au-
apo) were synthesized according to the following procedure. 
Solutions with a concentration of 500 mM potassium platinum (II) chloride 
(K2PtCl4) or 50 mM potassium gold (III) chloride (KAuCl4) were obtained by 
dissolving the corresponding salt in phosphate-buffered saline (PBS). Then a 
mixture of 10 % (v/v) buffer and 10 µM apoferritin was added to the solution. 
This final mixture was incubated for 2 h at 30 ºC. The excess metal salt was 
removed by passing the solution through a desalting column (40 kDa 
Molecular Weight Cut-Off (MWCO) from Thermo Scientific). The collected 
solution, containing the apoferritin encapsulated metal salt, was reduced with 
preloaded NaBH4 and incubated for 20 min at 30 ºC. For purification of the 
nanocomposite solution, the solution was passed again through a further 
desalting column (40 kDa MWCO). 
A similar procedure was followed for the synthesis of platinum-gold bimetal 
nanoparticles encapsulated within apoferritin (PtAu-apo). A solution with a 
concentration ratio of 1:100 of KAuCl4 and K2PtCl4 was prepared and used for 
the initial incubation. For enabling a meaningful comparison between PtAu-
apo and Pt-apo, a concentration of K2PtCl4 of 500 mM was used in both 
cases. After determining the protein concentration, the synthesized samples 
were stored at 4 ºC until further use. 
2.2.2 H/L heteropolymeric apoferritin  
The synthesis of heteropolymeric apoferritin with 10, 50 and 90 % L-chain 
protein content (mixture of H and L-chain proteins of ferritin) were obtained 
with the following procedure:  
Starting from recombinant pure H and L apoferritins, a proportional mixture 
was prepared. Then the apoferritins were disassembled by adding 1 M HCl 
solution until pH 2 was reached. Once the solution was stabilized at pH 2 the 
sample was shaken. Afterwards the pH was increased by adding 1 M NaOH 
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until pH 8 was obtained, which resulted in reassembly of the protein. After 
30 min, the heteropolymeric H/L apoferritin was purified using spin columns 
(40kDa MWCO). After determining the protein concentration, the samples 
were stored at 4 ºC. 
2.2.3 Sputtered gold on a silicon wafer  
Silicon wafers were first cleaned with isopropanol and subsequently sputter-
coated in two steps. At first, 10 nm of titanium was deposited, followed by 
40 nm of gold. The instrument used for this process was a LEICA EM 
MED020 sputter coater. 
2.2.4 Gold sample pre-treatment 
Samples pretreated with mercury: The gold covered silicon wafers were 
used to analyze the catalytic activity of gold in presence of mercury ions. For 
that, the gold samples where submerged in a solution containing 2 mM HgCl2, 
2 mM H2O2 and 10 mM PBS buffer over night. Before any further analysis the 
samples were cleaned by rising with water and isopropanol. 
The same method was applied for commercial gold nanoparticles. The only 
difference in the procedure relates to the duration of the treatment, being 1 h 
instead of overnight.  
Samples treated with ammonia: Some of the samples pretreated with 
mercury as well as some untreated gold samples were exposed to ammonia 
vapor. For that, the samples were placed on top of an open bottle of ammonia 
(28 %) in a well-operating chemical hood for less than 2 s.  
2.3 Characterization methods  
2.3.1 UV-Vis absorption spectroscopy 
UV-Vis spectroscopy is a characterization technique commonly used in 
chemistry and biology. The technique is based on the detection of the 
absorbed wavelength of UV-Vis irradiation, which is specific to the molecules 
present in the analyte.  
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The absorbance is calculated from the ratio between the transmitted light 
(I!"#) and the incident light (I!") with the following equation: 𝐴 =    log   (I!" I!"#) 
Before any absorbance measurement, the background spectrum must be 
measured in order to subtract any absorbance arising from the cuvette or the 
buffer.  
This spectroscopic method is commonly used for the determination of the 
concentration of a substrate. The correlation of the concentration of a 
substrate with its absorbance is given by the Lambert-Beer Law 
(Equation 2.1.).  
Equation 2.1. Lambert-Beer Law 
 𝐴 = 𝜀  ×  𝑙  ×  𝐶 
 
Herein 𝐴  is the absorbance of the analyte, 𝜀  the absorbance coefficient 
(l/mol·cm), 𝑙 the length of the optical pathway (cm) and 𝐶 the concentration of 
the analyte (mol/l). 
We applied this spectroscopic method for determining the protein 
concentration, for quantifying the amount of decomposed H2O2 and for 
following the reduction of Cytochrome c. While in some cases the spectra of 
the product were analyzed directly, in several other cases commercial kits 
were used to determine the desired component. Those cases will be 
individually explained in the following. In all cases the NanoDrop 2000c 
spectrometer from Thermo Scientific was used for recording the spectra.  
This instrument is very versatile in its application. It is able to measure spectra 
of samples in quartz or poly-(methyl methacrylate) PMMA disposable cuvettes 
(Figure 2.1 A), but is also able to measure spectra of small amounts of the 
analyte, for example droplets with volumes of 2-3 µl (Figure 2.1 B). For 
measuring reaction kinetics, the analyte can be stirred within a cuvette and 
the temperature can be controlled.  
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Figure 2.1. Photograph of a NanoDrop 2000c in A) cuvette measurement mode, and 
B) droplet measurement mode. 
 
Protein determination 
Protein determination or quantification was performed with two different 
methods. The selection of the method was depending on the component to be 
analyzed and consideration of foreseeable interferences. 
The Pierce® 660 nm Protein Assay Kit (Thermo Scientific) is a 
commercially available colorimetric detection method. The main advantages 
are that the solution is ready-to-use and the higher compatibility with buffers, 
detergents and reducing agents in comparison to other protein quantification 
techniques like Bradford.  
The tests were done according to the manufacture`s protocols. In summary, a 
protein-containing sample was mixed with a 15-fold volume of the assay 
solution. Then the mixture was incubated for 5 minutes at room temperature 
(RT) before the absorbance at a wavelength of 600 nm was measured by UV-
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Vis spectroscopy. The protein concentration was determined using a standard 
curve established by Bovine Serum Albumin (BSA) standard solutions 
(Thermo Scientific). 
The Bradford protein assay is a protein quantification technique based on 
the complex formation of the dye, Brilliant Blue G, and the protein. The tests 
were performed following the procedure established by the manufacturer. The 
absorption peak of the Bradford Reagent at 595 nm wavelength in presence 
of the protein was used to determine the protein concentration. The test 
consists of mixing 1 part of the analyte with 30 parts of the Bradford Reagent. 
The mixture was incubated at RT for 5 min before measurement. The data 
was compared with a standard curve of BSA with a known amount, which was 
used as reference. 
Catalase mimicking reaction 
The catalase-like activity was followed by measuring the remaining hydrogen 
peroxide concentration in the reaction sample upon its decomposition over 
time. For the quantification a commercially available assay kit, the 
PeroXOquantTM Quantitative Peroxide Assay Kit from (Thermo Scientific), 
was used. 
The assay kit is based on indirect quantification and was used according to 
the manufacturer`s instructions. This assay quantifies the Fe3+ - xylenol 
orange complex with a maximum absorption value at 560 nm. This complex 
forms in presence of hydrogen peroxide from the analyte and ammonium 
ferrous (II) sulfate (25 mM) and xylenol orange (125 M) from the assay kit. 
The Fe2+ is oxidized to Fe3+ by the hydrogen peroxide, which is subsequently 
complexed by xylenol. The quantity of the formed complex is proportional to 
the hydrogen peroxide present in the aliquot. 
The reaction performed to investigate the catalase mimic was as follows: 
In a pH constant environment, buffered with PBS at pH 7.4, the analyte 
containing 2-5 mg/ml protein concentration of Pt-, Au- or PtAu-apo or a 
corresponding amount of Au-nanoparticles was added. The reaction was 
started with the addition of 2 mM H2O2 to the solution. Before the 
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measurement, aliquots were taken at 0, 10, 20, 30 and 60 min and were 
diluted with water first in a 1:20 volume ratio and finally added to the assay kit 
solution in a 1:10 volume ratio. For the hydrogen peroxide quantification the 
final solution was incubated for 15 minutes at RT and the absorption at 
560 nm was measured. The concentration of H2O2 was calculated using a 
previously measured standard curve. 
Xylenol orange assay: 
The assay was performed at 30 ºC with a mixture of 0.1 mg/ml protein, 50 mM 
Tris-HCl buffer at pH 7.0 and 40 µM (NH4)2Fe(SO4)2. The reaction started with 
the addition of Fe2+. A 10 µl aliquot was taken from the reaction at 0, 5, 10, 
20, 30 and 40 min and mixed with 100 µl of a solution of 125 µM Xylenol 
Orange (XO) and 25 mM H2SO4. After incubation at RT for 20 min, the 
concentration of ferric ions in the aliquots was determined by measuring the 
absorbance at 595 nm 96. The autoxidation of the ferrous ions was controlled 
in the same assay conditions, but without addition of proteins. The aqueous 
solutions of (NH4)2Fe(SO4)2 with 25 mM H2SO4 were freshly prepared for 
each assay. 
The Zn2+ induced inhibition was measured with 10 mM ZnCl2 in the reaction 
mixture. The influence on the XO assay was determined by adding 10 µl of 
550 mM ZnCl2 to 100 µl 125 µM XO with 25 mM H2SO4 and the absorbance 
at 595 nm was measured for 15 min. 
Ferroxidase mimicking activity 
Ferroxidase catalyzes the oxidation of iron from Fe2+ to Fe3+. The mimic of 
this reaction by our composites was followed with UV-Vis spectroscopy in 
ambient conditions. The baseline was measured with 0.5 mM apoferritin 
protein and 10 mM Tris-HCl buffer at pH 7.0. The reaction started with the 
addition of (NH4)2Fe(SO4)2 in water to reach a final concentration of 40 mM 
and the changes in the absorption were recorded. 
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Cytochrome C reduction activity by ferritin 
Cytochrome C (Cyt-c) is a protein with characteristic UV-Vis absorption 
signals for each of the oxidation states. The oxidized form of Cyt-c has two 
dominating absorption peaks at 409 and 533 nm and the reduced form at 415 
and 550 nm. The kinetics spectroscopy method was used to follow the 
formation of reduced Cyt-c. The experiment set up was as follows: 
Inside a closed quartz cuvette, containing a mixture of 10 µM oxidized Cyt-c, 
10 mM Tris-HCl buffer at pH 7.0 and 0.5 mg/mL protein, an inert gas 
environment was formed by purging with 200 sccm 99.9999 % N2. After 
5 minutes of stabilization time absorption spectra were recorded and used as 
baseline. Further absorption spectra were recorded in intervals of 30 s during 
the first 120 s and in intervals of 15 s during further 900 s to follow the kinetics 
of the reduction reaction. Immediately after the measurement point at 90 s 
iron was added to the cuvette in form of (NH4)2Fe(SO4)2 to a final Fe2+ 
concentration of 50 µM. With the addition of iron, the Cyt c reduction started. 
Finally, the reaction yield was calculated photometrically. The concentration of 
the oxidized form of Cyt c was calculated at the starting point using the 
absorption peak at 409 nm (Δε = 1.06 x 105 M-1 cm-1). For the reduced form, 
the peak at 550 nm (Δε = 21.1 x 103 M-1 cm-1) 97 was used (Figure 2.2). 
The superoxide dismutase (SOD) inhibition test was performed by adding 
10 µg/mL of recombinant bovine SOD (≥ 2500 units/mg) directly to the 
reaction mixture. 
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Figure 2.2. Cytochrome c absorption spectra in its reduced and oxidized forms. 
 
Demineralization of Fe in Ferritin 
Demineralization of ferritin is a process that involves reduction of the iron 
within the ferritin. The demineralization was characterized by measuring the 
amount of Fe2+ ions released from the ferritin by complexing it with 3-(2-
Pyridyl)-5,6-di(2-furyl)-1,2,4-triazine-5`,5`-disulfonic acid (Ferene S) that 
selectively makes a complex with Fe2+ 98. The complex can be detected by 
measuring its characteristic absorption at 593 nm with UV-Vis spectroscopy. 
The demineralization process has been done with two different techniques, 
the classical chemical demineralization and with light induced 
demineralization. In the following both techniques will be described. 
Chemical demineralization was done using nicotinamide adenine 
dinucleotide (NADH) and flavin mononucleotide (FMN) as reducing agents. 
The reduction was performed at RT in inert conditions. For this purpose, the 
sample was purged with N2 for several minutes before the experiment and 
continuously during the experiment. The experiment was performed with 
75 µg/ml ferritin, 10 mM 2-(N-morpholino)ethanesulfonic acid (MES) buffer, 
2.5 mM Ferene S, 200 µM FMN and 2 mM NADH. The demineralization 
kinetics was followed by measuring absorption spectra at 593 nm in intervals 
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of 30 s. The baseline was recorded from the solution containing all 
components except NADH. The reaction started with the addition of NADH. 
Light induced demineralization was performed by illumination of the 
cuvettes with light emitting diodes (LED) having various wavelengths of 
emitted light, including BLUE (465 nm), GREEN (569 nm), YELLOW 
(588 nm), and RED (626 nm). The working solution was prepared from 
75 µg/ml ferritin, 10 mM MES, TRIS or PBS buffer and 2.5 mM Ferene S. The 
reaction was performed in an inert environment (purged with N2 for 5 min 
before starting the reaction and continuously during the reaction). Background 
spectra were taken before switching the light on and afterwards every 60 s 
during the reaction. The kinetic process was followed with recording the 
absorption peak of Ferene S at 593 nm. 
Analysis of the SOD activity 
For analyzing the SOD activity, the Assay Kit WST was used. It is based on 
the reaction between Dojido`s water-soluble tetrazolium salt (WST-1) and O2- 
superoxide ions. In this reaction O2- will be reduced and WST-1 formazan will 
be formed. The formation of WST-1 formazan is proportional to the amount of 
superoxide. The SOD activity of the nanoparticle-apoferritin composite will 
suppress the reaction by decreasing the amount of superoxide available for 
the reaction. This will cause an intensity decrease of the absorption peak of 
WST-1 formazan at 440 nm. Therefore, the SOD activity can be quantified by 
measuring the intensity variation of the WST-1 formazan peak.  
The measurement was done in a 96 well-plate with the following layout for 
each sample: 
Blank 1: dd H2O + WST-working solution + Enzyme working solution  
Blank 2: sample (ferritin composite) + WST-working solution + dilution buffer  
Blank 3: dd H2O + WST-working solution + dilution buffer  
Sample: sample + WST-working solution + Enzyme working solution  
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The enzyme working solution and WST-working solution were freshly 
prepared following the manufacturer’s instructions. The reaction mixtures in 
the plate were incubated for 20 minutes at 37 ºC before measuring the 
absorbance with the microplate-reader (Victor X5, PerkinElmer).  
The SOD activity was calculated from the absorbance values with the 
following Equation 2.2: 
Equation 2.2. SOD activity calculation 𝑆𝑂𝐷  𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 = (𝐴!"#$%  ! − 𝐴!"#$%  !) − (𝐴!"#$%& − 𝐴!"#$%  !)(𝐴!"#$%  !   −   𝐴!"#$%  !)   ×  100 
 
2.3.2 Gel electrophoresis (Native and SDS PAGE) 
Polyacrylamide gels were used to separate, identify and purify proteins by 
electrophoresis. It is a simple and rapid technique to resolve and quantify 
single proteins. Two types of polyacrylamide gel electrophoresis (PAGE) were 
used: a) native PAGE, where the protein conformation or protein bonds to 
other compounds can be detected, and b) sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE), which is used with 
denatured proteins for their later identification by Western Blotting 
(Figure 2.3).  
Western blotting is a commonly used analytical technique in biology, generally 
for protein detection, determination and quantification. The western technique 
requires a previous separation of proteins by gel electrophoresis. Thereafter 
the proteins are transferred from the gel to a nitrocellulose membrane by 
applying an electric field. The membrane is then treated with signal blocking 
proteins, usually BSA or fat free milk, and later with specific antibodies before 
the final protein detection is done with a second antibody.  
Native PAGE: 
Continuous native PAGE according to McLellan 99 was used to analyze the 
stability of the protein. Tris/Boric acid buffer (50 mM Tris, 25 mM boric acid, 
pH 8.7) was used both for the gel formation and as the running buffer. 
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Apoferritin, ferritin or metal containing apoferritin were mixed in a 1:1 ratio with 
the sample buffer and analyzed with a continuous 4 % native gel.   The 
sample buffer was prepared from 10 % Tris/Boric acid buffer, 30 % glycerol, 
2 % bromophenol blue (0.5 %) and purified H2O (Millipore).  Following the 
PAGE, the gel was stained with ImperialTM Protein Stain (Thermo Scientific). 
SDS PAGE: 
Proteins from cells were separated with a 14 % SDS-polyacrylamide gel 
adding a maximum of 25 µg of the protein to each well. After electrophoresis, 
the gel was stained with ImperialTM Protein Stain (Thermo Scientific). The 
intensity quantification of the proteins was performed with the Kodak 
Molecular Imaging Software. 
Protein detection with Western Blotting: 
The cellular membrane fractions were collected with the Mem-PER Plus 
Membrane Protein Extraction Kit (Thermo Scientific). 25 µg membrane 
proteins were separated with 4-20 % gradient Tris- glycine polyacrylamide 
gels for SDS-PAGE (Thermo Scientific) and electroblotted onto polyvinylidene 
fluoride (PVDF) (BioRad) with Trans-Blot® Turbo™ Transfer System (BioRad). 
PVDF membranes were blocked for 2 h at room temperature in 5 % BSA–
Tris-buffered saline/Tween 20 (TBST; 25 mM Tris HCl, pH 7.5/150 mM 
NaCl/0.05 % Tween 20). Following this, the membranes were incubated 
overnight at 4 °C with 1 µg/ml rabbit anti-ferroportin and anti-transferrin 
receptor antibodies. The following day, the membranes were washed four 
times with TBST and incubated at room temperature for 1 h with a 
peroxidase-conjugated anti-rabbit antibody (Thermo Scientific) in a 1:1000 
dilution as the secondary antibody. The rabbit anti- Na+/K+ ATPase antibody 
with a 1:15000 dilution from Abcam was used to detect ATPase in the cell 
membrane fractions. For the enhanced chemoluminescence detection the 
Amersham ECL Prime detection reagent was used and the signal was 
recorded with the C-DiGit Blot Scanner (LiCor Bioscience) 
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Figure 2.3. Schematic of the procedure for protein detection, starting from the cell 
culture. 
 
2.3.3 Atomic Absorption Spectroscopy (AAS) 
Atomic Absorption Spectroscopy is an analytic technique for the quantification 
of the metal content in a sample. Having a very high sensitivity, it is able to 
detect values lower than parts per billion (ppb). Also traces of elements can 
be detected. In AAS the sample is atomized and irradiated optically. The 
absorption of the irradiated light by the metal atoms in the gaseous state is 
measured and the concentration is quantified with the Lambert-Beer Law. 
The samples measured for this thesis were platinum nanoparticles within 
apoferritin with a protein concentration of 0,8 mg/ml. Measurement and 
determination of the concentration were done by the company BioSolutions in 
Halle, Germany. 
2.3.4 Physical characterization  
TEM, SEM, EDX and XPS 
Electron microscopy is a sensitive technique for physical and chemical 
characterization of nanostructures or nanocomposites. Common optical 
microscopes are limited to a resolution of 200 nm, as a consequence of 
operation with visible light. Electron microscopy uses an electron beam with 
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100 000 times shorter wavelength than visible light and in this way allows 
resolutions even to the atomic scale. 
Electron microscopy is used in two different ways; in transmission (TEM) the 
electron beam is passing through the sample and being detected. Areas in the 
sample with higher atomic mass will scatter the electrons locally, which will 
show a darker contrast on the detector plate. In (SEM) the electrons back 
scattered from the sample are detected, giving information on the morphology 
of the sample (Figure 2.4).  
 
 
Figure 2.4. Schematic representation of interactions of the electron beam with a 
sample and the resulting transmitted or backscattered electrons or rays. 
 
TEM can reach higher resolutions in imaging than a typical SEM, but the latter 
is more convenient for characterization of the morphology and topology of a 
sample. 
Pt-apo samples were characterized by TEM. The samples were pretreated 
with 1.5 % uranyl acetate and 250 µg/ml Bacitracin for negative staining, 
since the protein have a low atomic mass and therefore a weak contrast. 
Adding stains with a higher atomic mass is commonly used to visualize 
proteins in TEM. For a characterization by SEM, gold was sputtered on the 
surfaces in order to enhance the backscattering events and suppress surface 
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charging upon irradiation with the electron beam, which normally occurs with 
non-conductive samples and hinders an appropriate imaging.  
Both electron microscopes are equipped with Energy-dispersive X-ray 
spectroscopy (EDX) detectors that were used for the elemental analysis of the 
samples.  
Energy-dispersive X-ray spectroscopy (EDX) 
EDX is a powerful analysis technique that allows both qualitative and 
quantitative elemental analysis. Owing to the interaction between the electron 
beam and the sample, electrons from the inner shell of an atom are expelled. 
An electron from the higher valence level will drop down to fill the empty 
space. As a result of the energy difference, an X-ray will be emitted which will 
be detected. As those X-rays are characteristic for each element, it allows the 
elemental analysis to be carried out. 
X-ray photoelectron spectroscopy (XPS)  
X-ray photoelectron spectroscopy (XPS) is a technique to analyze the 
elemental composition and the chemical and electronic states of materials at 
the very surface of a sample. An X-ray beam interacts with the electron shells 
of the atoms located close to the surface of a sample. The electrons become 
excited and escape from the sample as a result of the photoelectric effect. 
Those electrons are recorded by the detector. Depending on the binding 
energy of the detected photoelectrons, the type of atom and its binding state 
to neighboring atoms can be identified. 
For XPS analysis, solutions of the analyte were deposited on a piece of Si 
wafer and dried in air. The XPS spectra were acquired with a spherical 
analyzer of the type EA 125 (Omicron) and a non-monochromatic Al-Kα 
(1486.6 eV) source. The measuring equipment was calibrated before use with 
the 4f line of a gold sample. All measurements were done at a working 
pressure less than 5 x 10-9 mbar and pass energy of 50 eV. Survey spectra 
(not shown) were made with a step size of 0.5 eV and an exposure time of 0.5 
s per measurement point. High-resolution spectra of the Pt 4f lines were 
recorded with a step size of 0.1 eV and an exposure time of 10 times 0.5 s per 
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measurement point. To eliminate the charging effect of the surface, all spectra 
were corrected with the help of the C 1s line. The position and intensity of 
each XPS line were determined by Voigt approximation with a linear 
background. 
2.4 In-Vitro Characterization 
2.4.1 Cell Culture 
The cell culture investigations were performed with the human colon 
adenocarcinoma cell line Caco-2 obtained from ATCC. The cells were 
cultured in minimum essential medium (MEM) supplemented with 10 % fetal 
Bovine Serum (FBS) (Biochrom), 1 % nonessential amino acids and 50 mg/ml 
gentamicin (37 ºC, 90 % humility, 5 % CO2).  
For passaging and seeding, the cells were released with trypsin/EDTA 
(0.05%/0.02%) solution once the cell confluence was about 80-90 %. The 
cells were subsequently seeded to 6-, 24- or 96-well plates at a concentration 
of 0.75x105 cells/cm2. The cell culture medium was replaced one day after the 
seeding and further every two days. The plates were cultured for 8 days for all 
the assays.  
2.4.2 Cell Viability 
The cell viability was determined with the Cell Counting Kit-8 (CCK-8). Cell 
viability was measured after each treatment of the cells. The treatments 
included the addition of iron and various ferritins and as well as treatments 
with blue light. 
After the treatment, the cells were washed twice with PBS and incubated with 
10 % CCK-8 solution in the culture medium for two hours. The quantification 
was done by measuring the absorbance at 450 nm using a microplate reader 
(Victor X5, PerkinElmer). The viability of untreated cells was set as 100 %. 
2.4.3 Cellular iron content: Ferene S assay 
The effects of metal nanoparticle containing apoferritin, apo-huFH, apo-huFL, 
huFH and Deferoxamine (DFO) on cells have been analyzed in an iron-
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excess environment. The cells were treated for two consecutive days with the 
final concentration of 0.1 µM protein or 200 µM DFO. On the second day the 
cells were treated with 100 µM ferric citrate with or without ascorbic acid 
(200 µM) for 24 h.  
The total cellular iron content was measured by incubating with 6 M 
guanidinium-HCl, 1 mM Ferene-S (3-(2-pyridyl)-5,6-di(2-furyl)-1,2,4triazine-
5’,5’’-disulfonic acid) and 250 mM ascorbic acid for 2 h at room temperature. 
Ferene-S and Fe2+ form a complex with the maximum UV-vis absorbance 
being at 600 nm. The measurements were carried out with a microplate-
reader (Victor X5, PerkinElmer). 
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Chapter 3 
Catalysis 
The first part of this chapter describes the inhibitory effect of 3-amino-1,2,4-
triazole (3AT), NaN3 or Hg2+ on the catalase and SOD enzyme mimetic 
activities of platinum nanoparticles synthetized within apoferritin (Pt-apo). A 
selective and specific inhibition of the mimetic activities through the choice of 
the inhibitor provides a novel way of tuning the activity of nanoparticles and 
suppressing undesired reactions. A strategy for recovery of the activity with a 
reducing agent will be demonstrated. The recovery treatment restores the 
surface chemistry of the nanoparticles and may even act as a general method 
for restoring the activity of numerous other nanoparticles.  
This first section describes the work published in the journal Chemical 
Communications from the Royal Society of Chemistry (RSC)100. Graphs, 
figures and parts of the text of the publication are reused in this thesis with 
permission of the publisher. 
Article:  
Tuning, inhibiting and restoring the enzyme mimetic activities of Pt–apoferritin. 
Unai Carmona, Lianbing Zhang, Le Li, Wolfram Münchgesang, Eckhard 
Pippel and Mato Knez. Chem. Commun., (2014), 50, 701-703 
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Schematic overview of the investigated catalytic reactions 
 
In the second part, the catalase-like activity of apoferritin encapsulated metal 
nanoparticles is studied. The catalase-like activity of platinum- and gold-
containing hybrid compounds is analyzed and special attention is paid to their 
reactivity upon contact with the heavy metal mercury. A mechanism for the 
reaction is proposed. 
An article is currently in preparation with the information and data described in 
the second part of this chapter. 
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3.1 Pt-apoferritin 
The catalytic properties of many nanoparticles and the special interest in them 
for chemical or biological applications were discussed in the introduction 
chapter 101,102. Often these catalytic reactions resemble the ones occurring 
with enzymes, including hydrogenation, oxidation and further reactions like C-
C coupling, etc 103,104. Although the catalytic reactions of nanoparticles often 
mimic enzymatic reactions, the reaction mechanisms, which inorganic 
nanoparticles and biomolecules undergo, are different. For example, the 
catalytic activities of nanoparticles are usually not specific to a substrate, 
while those of enzymes typically are. Pt-nanoparticles, for example, can mimic 
various enzymatic activities, such as oxidase, catalase and superoxide 
dismutase (SOD) 105–107, while the individual enzymes usually have only one 
of those activities. Also, biological enzymes usually have natural inhibitors, 
which regulate their catalytic activities, while possible inhibitors for 
nanoparticle-activated reactions still must be investigated. 
Heavy metals and many synthetic chemicals, such as sodium azide, can 
specifically or generally inhibit enzymatic activities 108. In view of potential 
future applications in enzyme mimetics, it is important to understand whether 
or not enzyme inhibitors act on nanoparticles in a similar way as they do on 
biological enzymes. 
3.1.1 Sample preparation 
Before the investigation of the enzyme-like activity of various hybrid 
bioinorganic compounds, those compounds were synthesized following 
protocols from earlier work of the group 95. The synthesis is described in 
chapter 2. Direct incubation of metal salts of platinum, gold or a combination 
thereof with apoferritin and their subsequent reduction, was identified as the 
most efficient pathway. In Figure 3.1 the simplified schematic of the process is 
shown. 
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Figure 3.1. Schematic representation of the preparation of platinum nanoparticles 
within apoferritin (Pt-apo). 
 
The resulting composite was characterized by UV-Vis spectroscopy and TEM. 
Figure 3.2 shows the resulting TEM images and size exclusion 
chromatography spectra 82. The protein concentration was measured with the 
Bradford method and the protein stability was analyzed by native gel 
electrophoresis. Table 3.1 summarizes the characteristics of each compound. 
 
Table 3.1. Synthesized compounds. 
 
 
Briefly, after the synthesis a minimum of 4 mg/mL protein concentration was 
measured for each of the samples, which was sufficient to reach a final 
protein recovery between 75 and 80 %. The nature of the buffer used for the 
synthesis has an influence on the size of the nanoparticles, which was subject 
of earlier investigation (Master thesis U.Carmona) 109. Here, as buffer for the 
synthesis of the nanoparticles PBS was chosen.  
 
 
 
Chapter 3 Catalysis 
	   39 
 
 
 
Figure 3.2. A) UV-vis absorption spectra of apoferritin, K2PtCl4 and Pt-apo. Apoferritin 
and Pt-apo were purified with a spin column before the measurements. The 
reference absorption spectrum was measured with purified water. B) Co-elution of Pt 
(450 nm) and apoferritin (280 nm) with size exclusion chromatography. C) TEM 
images of Pt-apo (Upper inset: high resolution electron micrograph of a platinum 
nanoparticle, scale bar: 2 nm; lower inset: TEM image of negatively stained Pt-apo, 
scale bar: 50 nm). 
 
The characterization techniques demonstrate the presence of platinum within 
the apoferritin structure. Furthermore, they show that the final reduction of the 
platinum ions inside the apoferritin was done successfully. The procedure did 
not affect the apoferritin shape and size, which remained intact according to 
the TEM images. With those compounds, we investigated the catalase 
mimicking reaction. Natural catalase reaction degrades H2O2, which is one of 
the most oxidative compounds occurring in organisms 110,111. The procedure 
followed for the kinetic analysis of the catalase activity was described by 
Zhang et al 95.  
The protein stability of the compounds was measured using native gel 
electrophoresis. The corresponding image is shown in Figure 3.3. Untreated 
ferritin and apoferritin mark the control bands. No significant changes were 
observed besides the already mentioned effect of the buffer on the size of the 
nanoparticle. The protein remained its size and charge. 
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Figure 3.3. Native PAGE: 4% native gel was stained with ImperialTM Protein Stain 
(Thermo Scientific) after the electrophoresis. Transferrin (Trf) was used as control. 
(H) and (P) indicate the buffer (HEPES or PBS) used for the synthesis 109. 
(Reproduced from the Master thesis U. Carmona) 
 
3.1.2 Tuning, Inhibiting and Restoring 
In this section the catalase and SOD enzyme mimetic activities of Pt- were 
characterized. The main objective was to analyze the influence of various 
inhibitors on the compound’s activity. For this purpose several natural 
inhibitors for catalase or SOD activity were chosen, NaN3 as general inhibitor, 
HgCl2 as heavy metal based inhibitor for both catalase and SOD, and 3AT as 
catalase-specific inhibitor 112. To follow the reaction, the initial concentration of 
the substrate H2O2 was measured and set to 100 %. After 10, 20 and 30 min 
of reaction time the remaining H2O2 was determined and the degradation 
quantified.  
Before starting with Pt-based catalysts, the effects of apoferritin and the 
inhibitors on the hydrogen peroxide decomposition reaction were analyzed. 
Figure 3.4 shows that those three components did not contribute to the 
decomposition of H2O2. The concentration of H2O2 remained stable between 
ca. 90 % and 100 % over the whole measurement period. 
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Figure 3.4. Activity of horse Spleen apoferritin (apo-hoSF): H2O2-content in the 
reaction solution in presence of various inhibitors as function of time. Assay 
conditions: 30 ºC, pH 7.4, 1.875 mg/ml Pt-apo, and 2 mM initial H2O2. 
 
Once contribution of the inhibitors and apoferritin to the hydrogen peroxide 
decomposition were excluded, the same experiments were done in presence 
of Pt-apoferritin. 
 
 
Figure 3.5. Activity of Pt-apo: H2O2-content in the reaction solution in presence of 
various inhibitors as function of time. Assay conditions: 30 ºC, pH 7.4, 1.875 mg/ml 
Pt-apo, and 2 mM initial H2O2. 
 
The graph in Figure 3.5. shows that in absence of inhibitors 65 % of the initial 
hydrogen peroxide was decomposed by Pt-apo within 30 min. In presence of 
10 mM NaN3, less than 25 % of the initial H2O2 were decomposed within 
30 min. The inhibitory effect was even more pronounced with 10 mM Hg (II) or 
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3AT, being nearly quantitative with those two reagents. All three inhibitors 
exhibited a concentration-dependent inhibition (Figure 3.6). 
 
 
Figure 3.6. Peroxide decomposition activities in presence of inhibitors (upper row) 
and activity vs. inhibitor concentration (lower row). A) 3AT. B) NaN3. C) Hg2+. 
Common assay conditions: 30 ºC, PBS pH 7.4, 1.5 mg/ml Pt-apo and 2 mM H2O2. 
Blue curve: without inhibitor; red curve: 10 mM inhibitor; green curve: 1 mM inhibitor; 
purple curve: 0.1 mM inhibitor. 
 
The activity versus inhibitor concentration curves in Figure 3.6 indicate 
different inhibition mechanisms among the samples. The amount of inhibitor 
necessary to reduce the activity of Pt-apo can be extracted from the curves. 
Around 1 mM NaN3 or Hg2+ is sufficient to reduce the activity by more than 
50 %. In case of 3AT, the tenfold concentration (10 mM) was necessary to 
reach similar values. 
To obtain more information about the reaction mechanisms, Pt-apo was 
incubated over night with 10 mM inhibitor and subsequently purified with a 
spin column before the catalase activity was analyzed. This test allows 
determining the affinity or type of interaction between the inhibitor and the 
platinum surface that is likely to be the active side for the enzymatic activity. 
Figure 3.7 shows that without further inhibitor added to the assay solution, the 
pretreated Pt-apo decomposed less than 40 % of the initial H2O2. This 
indicates that the inhibitor competes with the substrate for the adsorption sites 
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on the Pt-nanoparticle surface in a dominant way. Thus, the inhibitory effect 
can be explained with a reduced active surface. 
 
 
Figure 3.7 H2O2-decomposition activity of Pt-apo and inhibitor-pretreated Pt-apo. 
Assay conditions: 30 ºC, pH 7.4, 1.5 mg/ml Pt-apo or pretreated Pt-apo, and 2 mM 
H2O2.  
 
In the next step, the inhibitory effect of NaN3 or 3AT on the SOD activity of Pt-
apo was analyzed in order to verify whether or not the inhibition is reaction 
specific. Hg2+ could not be evaluated, since it readily inhibits the superoxide 
generation in the SOD assay system (Assay Kit-WST), even without addition 
of the nanocomposite. NaN3 did not inhibit the SOD activity of Pt-apo, while 
3AT inhibited 20 % of the relative SOD activity (Figure 3.8)  
 
 
Figure 3.8. Inhibition effect of 10 mM 3AT or NaN3 on the SOD activity of Pt-apo.  
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In a further experiment, Pt-apo was treated with the aforementioned two 
inhibitors and H2O2 over night and the relative SOD activity was tested after 
purification. While more than 20 % of the SOD activity was inhibited upon 3AT 
treatment, the activity of NaN3- and H2O2-pretreated Pt-apo did not 
significantly alter in comparison to untreated Pt-apo (Figure 3.9). Together 
with the previously described catalase inhibition, these results indicate that 
inhibitors can influence the enzyme mimetic activities of nanoparticles in a 
reaction-specific manner. This provides a novel combinatorial way to make 
nanoparticles tunable and flexible catalysts by using inhibitors to selectively 
suppress their activity, inhibiting the catalase activity with NaN3, or inhibiting 
both catalase and SOD activities with 3AT. 
The competitive adsorption of 3AT on NPs can explain its inhibition of both 
catalase and SOD mimetic activities. However, the same theory alone cannot 
justify the selective inhibitory effects of NaN3 113. It has been observed that 
superoxide can form singlet oxygen in absence of the enzyme 114. NaN3, but 
not 3AT, is a strong quencher of singlet oxygen. In our case, the singlet 
oxygen may form during the SOD-like reaction and react with NaN3 adsorbed 
on the NP surfaces, which will probably remove the adsorbed azide and 
abrogate the inhibition. Since superoxide and singlet oxygen are not involved 
in the catalase reaction, azide ions will remain absorbed and cause the 
inhibition. 
 
Figure 3.9. Inhibition of the SOD activity of Pt-apo upon its pretreatment with H2O2, 
NaN3 or 3AT. The concentrations of H2O2, NaN3 and 3AT for the pretreatment: 8, 100 
and 100 mM, respectively. 
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Inhibition of biological enzymes is often irreversible, resulting in a permanent 
loss of activity 115. Enzyme mimetic nanoparticles, composed of a robust 
protein and even more robust inorganic core might be superior to their 
biological counterparts and the previously described inhibition of the activity 
might potentially be reversible. Many established methods for protein 
purification provide the possibility to easily recycle Pt-apo from a reaction 
mixture. This is, in turn, advantageous for investigating the activity recovery of 
Pt-based catalysts. 
 
 
Figure 3.10. The change of the catalytic activity of Pt-apo after multiple reaction 
cycles and final treatment with NaBH4 (orange line, not normalized with the Pt 
amount). After each cycle the Pt-apo was separated from the reaction mixture with a 
spin column.  
 
The H2O2 decomposition activity of Pt-apo decreased with each of the four 
serial reaction cycles (Figure 3.10). Figure 3.11 shows that no significant 
change in the particle size occurred and most of the apoferritin still showed an 
intact protein shell. Since H2O2 is an oxidizing agent, the reason for the 
reduction of the catalytic efficiency could be an oxidation of the surface or 
adsorption of oxygen or some other oxygen species onto the Pt catalyst 
during the reaction 116,117. 
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Figure 3.11. TEM images of A) Pt-apo after the peroxide decomposition reaction. B) 
The intact protein shell was visualized by negative staining with 1.5 % uranyl acetate. 
 
An adsorption of oxygen species during storage was excluded with a 
reference measurement of the bare sample after 4 weeks of storage resulting 
in almost identical kinetics (Figure 3.12).  
 
 
Figure 3.12. Activity change of Pt-apo after storage in water at 4 oC for 4 weeks.  
 
If the assumption of poisoning in the oxidative environment holds, a removal 
of the adsorbed oxygen species would logically restore the catalytic activities. 
In order to prove this, Pt-apo was first treated with 1.32 mM H2O2 in sum 
(equal to four reaction cycles) and subsequently treated with the reducing 
agent NaBH4 for 5 min. Following this treatment the peroxide decomposition 
activity of Pt-apo was measured for comparison. The activity of Pt-apo after 
reduction indeed increased again as compared with the fourth cycle 
(Figures 3.13 and 3.10).  
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Figure 3.13. Change of the catalytic activity of Pt-apo after multiple reaction cycles 
and final treatment with NaBH4 (orange line). The activity of Pt-apo was normalized 
with the Pt quantity determined by atomic absorption spectroscopy (AAS) 
(Table 3.2). The normalization was done by calculating the percentage of 
decomposed H2O2 per minute per ppm Pt for the corresponding time. 
 
Table 3.2: Concentration of platinum measured with atomic absorption 
spectroscopy (AAS). 
 
Sample Cycle1 Cycle2 Cycle4 NaBH4 
Platinum 
concentration (ppm*) 
288.48 
±16.11 
281.15 
±25.04 
199.09 
±37.76 
207,36 
±17.31 
* parts per million (ppm); the protein concentration of the samples was 0.8 
mg/ml. 
A similar effect was also observed if another common reducing agent, H2 gas, 
was used (Figure 3.14). After the removal of the oxygen on the surface, the 
catalytic activity increased and resembled closely the activity of untreated Pt-
apo. 
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Figure 3.14. A) Recovery of the activity of Pt-apo for the H2O2 decomposition 
reaction with hydrogen gas (5 % in Argon) after 4 reaction cycles.  
 
The changes of the surface of the Pt induced by a potential adsorption or 
oxidation, as well as after treatment with NaBH4, were investigated with XPS. 
The Pt 4f7/2 peak position of Pt-apo shifted from 71.4 eV to 71.9 eV after the 
H2O2 decomposition reaction and shifted back to 71.5 eV after treatment with 
NaBH4 (Figure 3.15). The XPS measurements demonstrate that the changes 
induced by the decomposition reaction could be recovered after treatment 
with NaBH4. This indicates that a reversible surface chemistry is the origin of 
the restorable activity.  
 
Figure 3.15. XPS Spectra of initial Pt-apo (black), after the reaction with H2O2 
(green), and after treatment with NaBH4 (red). The spectra show the Pt 4f7/2 and the 
Pt 4f5/2 photoelectron spectral lines with the corresponding background. The 
corresponding Pt 4f7/2 position is indicated with vertical lines in the same color.  
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Finally, the reducing agent was tested for its ability to restore the inhibited 
SOD activity of 3AT- and NaN3- treated Pt-apo compounds. The effects of the 
reducing agent on the protein fraction of the hybrid composite were clearly not 
the reason for the recovery (Figure 3.16). 
 
Figure 3.16. SOD activity of untreated, 3AT-treated and NaBH4-treated (after 3AT 
pre-treatment) Pt-apo. Protein concentration: 550 µg/ml apo-hoSF, 44 µg/ml Pt-apo.  
 
3.1.3 Summary 
In summary, the enzyme mimetic activities of ferritin-encapsulated platinum 
nanoparticles can be inhibited with inhibitors typically active with biological 
enzymes. NaN3 inhibited only the catalase activity of Pt-nanoparticles, but not 
the SOD activity, while 3AT inhibited both catalase and SOD activities, 
indicating the possibility to achieve selective and specific activity suppression 
with inhibitors. This opens the door towards controlling the activities of 
nanoparticles in a reaction specific manner with further inhibitor screening, 
which is greatly interesting for nanoparticle engineering for targeting enzyme 
mimetics. The demonstrated activity recovery of catalytic activities with 
NaBH4, restoring the chemical properties of the nanoparticle´s surface, 
promise to be a more universal technique for the regeneration of the 
nanoparticles, which is not limited to catalytic applications. 
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3.2 Au-apoferritin 
In the following section the catalase–like enzyme mimetic activity of gold 
treated with mercury ions is studied 118. The reason for this study results from 
the observation that mercury ions show peculiar behavior in the 
decomposition of H2O2 if combined with gold nanoparticles, which justifies a 
more in-depth analysis.  
Many studies in literature investigated the combination of gold, mercury and 
H2O2 for the sake of mercury detection or hydrogen peroxide 
decomposition 118–120. However, none of those shows a conclusive reaction 
mechanism of the involved catalytic processes. Moreover, the studies are 
often contradictory. In the following, a reaction mechanism will be proposed 
based on our experiments on the catalase activity. 
We used the previously described platinum (Pt-apo), platinum-gold (PtAu-
apo) and gold (Au-apo) nanoparticles. The synthesis of the particles is 
described chapter 2.  
Those synthesized hybrid components were analyzed for their catalase 
activity or H2O2 decomposition in presence and absence of mercury 
(II) chloride (HgCl2). For this purpose, the initial concentration of the substrate 
H2O2 was measured and the decomposition percentage was calculated after 
measuring the remaining H2O2 after one hour of reaction time, similar to the 
previous chapter. 
3.2.1 Hg effect on Au apoferritin 
 An evidence of Hg2+ influencing the catalase activity of Au-apo is shown in 
Figure 3.17. Without Hg2+, Pt-apo showed the highest activity among the 
three types of nanoparticles decomposing more than 75 % of initial peroxide 
within one hour. For comparison, PtAu-apo decomposed less than 50 % and 
Au-apo only 4 % of the H2O2. Adding 1 mM Hg2+ changed the reactivity of the 
composites significantly. 
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Figure 3.17. Percentage of decomposed H2O2 after one hour of reaction time. For the 
reactions Pt-apo, PtAu-apo or Au-apo (0.5 mg/ml), 10 mM PBS buffer and 2 mM 
H2O2 were used; 1 mM HgCl2 was added to the reactions marked with red bars.  
 
In the case of Pt-apo, the reactivity of the compound upon addition of Hg2+ 
decreased to very low reaction rates showing a clear inhibitory effect. A 
similar observation was done in the previously described section. In contrast, 
the reactivity of PtAu-apo and Au-apo was greatly enhanced with the addition 
of HgCl2. In detail, PtAu-apo without Hg2+ decomposed 45 % of the initial 
H2O2, while upon adding Hg2+ it decomposed more than 95 % of the H2O2. 
More interestingly, Au-apo showed almost no activity prior to adding Hg2+, but 
became active in presence of Hg2+ with a decomposition rate of more than 
25% (Figure 3.17). 
To verify the observed effect, the behavior of the mercury ions only within the 
reaction setup as well as in the detection method were analyzed first 
(Figure 3.18 A). After that the activity of apoferritin in contact with mercury 
ions was studied (Figure 3.18 B). Those tests showed that Hg2+ does not 
affect the peroxide decomposition and the reactivity of apoferritin. Thereafter, 
the reactivity of the hybrid nanoparticles was evaluated. The experiments 
showed that the enhancement of the reactivity must be due to some 
interaction between the gold nanoparticle and mercury. 
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Figure 3.18. Percentage of decomposed H2O2 after one hour of reaction time. A) 
Control experiment without apoferritin under following conditions; 10 mM PBS buffer, 
2 mM H2O2 and 1 mM Hg2+. B) Control experiment with 0.5 mg/ml apoferritin, 10 mM 
PBS buffer, 2 mM H2O2 and 1mM Hg2+. 
 
The catalase activity of commercial PBS-stabilized gold nanoparticles was 
tested in similar conditions. Two further tests with commercial gold 
nanoparticles were performed, one without mercury, to be used as control, 
and one with 1 mM HgCl2 added. The gold nanoparticle concentration used 
for the assay was calculated from the intensities at the UV-Vis spectra peaks. 
 
 
Figure 3.19. Percentage of decomposed H2O2 after one hour of reaction time. 
Control with commercial PBS-stabilized 10 nm Au nanoparticles in 10 mM PBS 
buffer and 2 mM H2O2; 1 mM of HgCl2 was added for the test with Hg2+.  
 
The results presented in Figure 3.19 show that addition of Hg2+ results in 
significant enhancement on the peroxide decomposition activity. Even after 
1 h of incubation, no H2O2 decomposition was observed from the control 
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sample. In presence of Hg2+, more than 55 % of the initial H2O2 was 
decomposed, in analogy to the previous experiment performed with 
apoferritin-encapsulated gold nanoparticles. 
The gold nanoparticles were characterized by SEM (Figure 3.20). The images 
show that without addition of Hg2+ the gold nanoparticles remain intact in the 
reaction conditions. The size and morphology of the nanoparticles were not 
affected (Figure 3.20 A). In contrast, a change in morphology was observed 
once Hg2+ was introduced into the reaction (Figure 3.20 B). Namely, the 
nanoparticles agglomerated and partly merged. A similar observation was 
recently done by Schopf C et al. upon exposing gold nanorods to Hg2+ 121. 
 
 
Figure 3.20. SEM images of PBS-stabilized Au nanoparticles after 1 h of reaction 
time with 2 mM H2O2 in PBS, A) without and B) with added Hg2+. The insets show 
magnified images of the nanoparticles. (scale bar 10 nm; inset: 2 nm) 
 
A reaction between Hg2+ and the Au nanoparticles clearly occurs, most likely 
even before initiating the peroxide decomposition activity. For a similar 
observation, Yi Juan Long et al. proposed that the Hg2+ becomes first reduced 
to Hg0 by the citrate present on the surface of the Au nanoparticle and then 
the peroxide decomposition occurs with this composite 120. However, in our 
system the commercial nanoparticles are stabilized with PBS and in case of 
Au-apo by the protein cover and not citrate. Therefore such interpretation is 
not applicable to our case.  
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3.2.2 Hg effect on sputtered Au 
To further evaluate the material system, Au was sputter-deposited on silicon 
samples. Such deposited gold does not have stabilizing buffers or proteins, 
but neat gold surfaces are subjected to the reaction. The sample morphology 
was initially characterized by Atomic Force Microscopy (AFM) (Figure 3.21).  
 
 
Figure 3.21. AFM image of the sputter-deposited gold surface.  
 
The topological surface analysis of the gold samples showed uniform 
roughness. The nanoparticles forming the gold layer had an average size of 
60 nm. While the size of the nanoparticles was larger than that of commercial 
PBS-stabilized nanoparticles, they are within the same order of magnitude, so 
the results from those analyses may be extrapolated to the commercial 
nanoparticles or Au-apo samples. 
The sputter deposited gold samples were incubated in the same conditions as 
the nanoparticles. For the peroxide decomposition test, samples with and 
without added mercury were used. After one hour of reaction time, no serious 
visual changes were observed, thus longer incubation periods were applied. 
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Figure 3.22. A) Photograph of sputter-deposited gold on Si. Both samples were 
treated with PBS, H2O2 and the right sample additionally with Hg2+. B) SEM images 
of the samples shown in A). (Scale bar: 50 µm). C) EDX spectra of the samples 
shown in A). 
 
In Figure 3.22A gold-sputtered silicon wafers are shown. The left sample was 
treated with PBS and H2O2, but not Hg2+ It shows no alteration in appearance, 
but remained mirror-like. The right sample was treated with Hg2+, PBS and 
H2O2. After the overnight reaction some white precipitate was observed. The 
SEM images show some crystal formation covering the gold surface and the 
EDX spectra confirm that the crystals contain mercury and chlorine 
(Figure 3.22 C). The crystal formation may result from mercury (I) chloride 
(Hg2Cl2), which has a much lower solubility in water than other mercury salts. 
This insoluble salt probably precipitates onto the gold surface. 
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Hg2Cl2 is very difficult to solubilize. In order to prove the insolubility of the 
precipitate, the samples were rinsed in large amounts of water for one week. 
Only limited solubility of the precipitate was observed (Figure 3.23). 
 
 
Figure 3.23. SEM images of the precipitates on gold surfaces A) before and B) after 
testing the solubility. The treatment involved immersing the sample in large amounts 
of water and changing the water every day.  
 
The presence of Hg2Cl2 was chemically analyzed with a classical chemical 
detection reaction with ammonia, according to the following equation: 
 
3.1 Equation 
  Hg2Cl2  +  2NH3  →  Hg  +  Hg(NH2)Cl  +  NH4Cl 
 
In Figure 3.24 one can see that the after a short exposure to ammonia vapors 
the sample turns black (Figure 3.22 A). Since the reaction occurs with Hg2Cl2 
only, but not with HgCl2, the color change proves the presence of Hg2Cl2. 
Consequently, it confirms that Hg2+ was reduced to Hg+ and the formed 
precipitate consists of Hg2Cl2.  
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Figure 3.24. Photograph of gold-sputtered Si samples from Figure 3.22A after 
exposure to ammonia vapors. The right (black) sample contained precipitates after 
treatment with Hg2+ prior to the color change. 
 
The presence of Hg2Cl2 implies that a redox reaction between Au and Hg2+ 
happens, which reduces the Hg2+. First, a possible effect of H2O2 was 
analyzed. For that, a gold sample was treated with 1 mM HgCl2 solution and 
PBS buffer, but without adding H2O2.  
 
 
Figure 3.25. SEM image of a precipitate on the gold surface. The sample was treated 
with 1 mM HgCl2 and 10 mM PBS buffer for 4 h. (Scale bar 10 µm) 
 
After 4 h of reaction time, only few areas of the surface area contained small 
amounts of Hg2Cl2 precipitates on top of the gold surface (Figure 3.25). This 
shows that H2O2 is necessary for the formation of Hg2Cl2.  
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As control, silicon wafers without gold coverage were incubated in the same 
conditions. The SEM images did not show any precipitation and EDX spectra 
confirmed absence of Hg on the sample surface (Figure 3.26). Consequently, 
gold plays a critical role in this reaction. 
 
 
Figure 3.26. A) SEM image of a silicon wafer surface incubated over night with 1 mM 
HgCl2, 10 mM PBS and 2 mM H2O2 (scale bar: 50 µm). A) EDX spectrum of the 
sample shown in A). 
 
The two types of ions needed for the formation of Hg2Cl2 are Hg+ and Cl-. By 
removing the chloride from the reaction solution, the formation of the crystals 
on top of the gold surface should be suppressed. Removal of the PBS buffer 
resulted in the precipitation of crystals with different morphology and size 
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(Figure 3.27). This effect can be explained with PBS providing a significant 
amount of Cl- ions to the solution, enforcing nucleation and precipitation very 
rapidly. 
 
 
Figure 3.27. SEM image of precipitates on the gold surface. Treatment of the sample 
was done by immersing into a solution containing 1 mM HgCl2 and 2 mM H2O2 over 
night.  
 
The exact mechanism for the Hg2+ reduction is difficult to prove at this stage. 
One further experiment with the sputter-coated gold surface having been 
exposed to mercury vapors showed a strong reactivity with H2O2. For this 
experiment a gold-sputtered silicon wafer was introduced into a closed glass 
container containing a small droplet of liquid Hg and kept there overnight. The 
Hg was not in touch with the gold, but the Hg vapor should interact with the 
surface. The resulting gold surface showed a heavy reaction with 
concentrated H2O2. Untreated gold samples, as expected, did not show any 
activity. This indicates that the catalytic reactivity is related to an interaction of 
gold with mercury, most likely resulting in an amalgam. Such amalgam 
formation may be the reason for the fusion of nanoparticles observed in 
Figure 3.20. Therefore, the exposure to Hg2+ and the resulting high catalytic 
reactivity is very likely to originate from an intermediate Hg0 formation and 
subsequent alloying with Au. From the performed experiments, it becomes 
clear that H2O2 plays an important role in this process. On the one hand, H2O2 
may reduce Hg2+ to Hg+, which would subsequently disproportionate to Hg0 
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and Hg2+, leaving behind some Hg+, which will precipitate with Cl-. However, 
this possible pathway implies that the splitting of H2O2 on gold will produce 
reducing agents, which cannot be easily evidenced. On the other hand, 
reactive oxygen may be formed on the gold, which could oxygenate the Hg2+ 
forming HgO. Such HgO, especially if freshly prepared, may not be very 
stable and it could decompose. Indeed, decomposition of HgO is also used in 
the production of mercury 122. Regardless of the possible pathway, Hg0 will be 
generated and dissolve in Au to form an amalgam, which will act as catalyst 
for the decomposition of H2O2. 
In order to clarify the nature of the previously shown H2O2 decomposition 
reaction being either a catalase- or a peroxidase-mimicking reaction, 
experiments with added 3, 3´, 5, 5´-tetramethylbenzidine (TMB) were 
performed. This chemical is commonly used as substrate for quantifying the 
peroxidase reaction kinetics. The negative results demonstrate that the 
decomposition reaction was not due to a peroxidase activity (Figure 3.28). In 
consequence, the reaction is described as catalase, which agrees with similar 
observations made by Chao-Wei Tseng et al. with platinum/gold 
nanoparticles 123. 
 
 
Figure 3.28. Peroxidase activity analysis performed by comparing the absorption of 
the oxidized state of TMB at 650 nm. The reaction was performed with the 1-Step™ 
TMB-Blotting Substrate Solution from Thermo scientific. 
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3.2.3 Summary 
The effect of the mercury ions on the catalase mimetic activity was 
demonstrated for various metal nanoparticles encapsulated within the 
apoferritin cavity. The inhibitory effect on Pt-apo compounds was contrasted 
with an activation of the catalytic activity in case of Au-apo. The effect of 
mercury on Au was investigated. The enhanced reactivity is most likely 
related to an amalgam formation as a result from either a reduction of Hg2+ 
and disproportionation or decomposition of HgO, which will yield Hg0 to form 
an amalgam with gold. The precipitate was identified as Hg2Cl2, but appears 
to be a side product in this process. 
 
	  	  62 
 
 
 
	  	   63 
Chapter 4 
Enzyme mimetics: Ferroxidase 
In the following chapter, the functionality of the ferritin protein for potential in 
vitro applications is investigated. The activities of the protein besides the 
naturally present functions are analyzed in a cellular environment and in 
biological conditions. Furthermore, the use of nanoparticles as the ferroxidase 
mimicking active site is evaluated 124,125. The well-established method detailed 
in the previous chapter was applied for synthesizing metal nanoparticles 
within the cavities of human L-chain (apo-huFL) and H-chain (apo-huFH) 
apoferritins. Such compositions, especially with gold or platinum 
nanoparticles, are well-known to exhibit oxidase activities 93,94,100,124,126, giving 
rise to the assumption that ferroxidase activity can be induced. 
The work described in the present chapter is published in the journal 
Chemical Communications from the Royal Society of Chemistry (RSC). 
Graphs, figures and parts of the text of the publication are reused in this 
thesis with permission of the publisher127. 
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Article:  
Semi-artificial and bioactive ferroxidase with nanoparticles as the active sites. 
L. Li, L. Zhang, U. Carmona and M. Knez. Chemical Communications., 
(2014), 50, 8021-8023 
 
 
Schematic overview of the investigated catalytic reactions 
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4.1 Nanoparticles as active sites 
Ferroxidases are important for the cellular transport and the storage of iron. 
This metal is essential for many biological enzymes, the O2 transport, the 
immune defense, the energy metabolism, etc. Impaired ferroxidase activity is 
found to contribute to the generation or progress of diseases 128–130. For 
example, the ferroxidase activity of ceruloplasmin is oxidatively inhibited by 
the Parkinson’s disease 131. The ferroxidase activity of the b-amyloid protein 
precursor (APP) is specifically inhibited by Zn2+ in Alzheimer’s disease132. 
Besides APP, Zn2+ also inhibits the ferroxidase activity of heavy chain 
(21 kDa) ferritin. The L-chain (19 kDa) has no ferroxidase activity. However, in 
presence of L-chain proteins a more efficient mineralization of ferric ions 
occurs inside the cavity 133. Thus, it appears feasible that a stable ferroxidase 
with efficient iron mineralization ability can be assembled from an inorganic 
ferroxidase mimic and L-chain proteins. The inorganic nanoparticle should 
oxidize ferrous ions to ferric ions, while the protein should mineralize the ferric 
ions, which would otherwise precipitate in an aqueous environment. 
UV-vis spectroscopy was performed in order to determine the kinetics of the 
catalytic reactions of the composite upon iron oxidation under aerobic 
conditions. An absorbance peak at around 300 nm is characteristic of 
ferroxidase-catalyzed iron oxidation 134,135. Rapid oxidation of iron within 
seconds was observed with apo-huFH, which exhibits natural ferroxidase 
activity (Figure 4.1A).  
As expected, apo-huFL was ferroxidase inactive and the spectra at 250–
300 nm showed only non-enzymatic iron oxidation. However, enzymatic iron 
oxidation was observed with platinum nanoparticle containing L-chain 
apoferritin (Pt-huFL). The stepwise progressing iron oxidation with Pt-huFL 
indicates that the mechanism of the nanoparticle surface-catalyzed 
ferroxidation is different to that of an amino acid residue-catalyzed reaction by 
apo-huFH, presumably related to fundamentally different binding, conversion 
and dissociation chemistry of substrates and products. Despite the slower 
conversion rate of Pt-huFL, similar total iron oxidation rates were achieved 
with both Pt-huFL and apo-huFH. Note that the ferroxidase activity of the 
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nanoparticles is material specific: encapsulated gold nanoparticles (Au-huFL) 
did not exhibit ferroxidase activity (Figure 4.1).  
 
 
 
 
Figure 4.1. Ferroxidase activity of various apoferritins with and without Pt or Au 
nanoparticles, kinetically measured within 2 min of reaction time by UV-vis 
spectroscopy. The reaction was performed with 1 mM protein, 40 mM Fe2+ and 
50 mM Tris at pH 7.0. Arrows indicate the ferroxidase activity evolution. 
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Figure 4.2. Influence of Zn2+ on the XO assay. 50 mM ZnCl2 together with 25 µM 
FeCl3 or 100 µM (NH4)2Fe(SO4)2 were added to the assay solution. The absorption at 
595 nm was measured for 15 min in intervals of 30 s. 
 
The evolution of Fe3+ was recorded with xylenol orange (XO). The XO assay 
is specific for Fe3+, even in presence of Zn2+ (Figure 4.2), but will not react 
with Fe2+. After 6 min almost all ferric ions present in the assay conditions 
were chelated. This high selectivity makes the XO assay very well suitable for 
the quantification of the ferric ions upon Pt-huFL catalyzed ferroxidation.  
 
 
Figure 4.3. Fe3+ evolution over time upon reaction of various apoferritins with Fe2+, 
with and without inhibitors, determined with the XO assay. The assay was performed 
with 0.2 mM protein, 10 mM Fe2+ and 50 mM Tris buffer at pH 7.0. The inhibition of 
the ferroxidase activity was performed in the presence of 10 mM Zn2+.  
 
With the XO assay, the formation of products (Fe3+) is determined rather than 
the initial rate of ferroxidation, which allows for determination of the 
contribution of apo-huFL to the overall reaction. In this experiment, catalytic 
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conversion of ferrous to ferric ions was observed with apo-huFH and Pt-huFL 
and a non-enzymatic formation of ferric ions with apo-huFL (Figure 4.3). The 
evolution of ferric ions with apo-huFH reached a quasi plateau after 10 min, 
while it was incessant with Pt-huFL during the whole assay period, resulting in 
a higher final ferric concentration (Figure 4.3).  
 
 
Figure 4.4 Ferroxidase activities of apo- and Pt-huFH measured with the XO assay. 
The assay was performed with 0.2 µM protein, 10 µM Fe2+ and 50 mM Tris buffer at 
pH 7.0.  
 
The incessant production of Fe3+ with Pt-huFL indicates that the Pt 
nanoparticles altered the reaction mechanism and facilitated a more 
consistent ferroxidation than the natural ferroxidase apo-huFH (Figure 4.4). In 
order to verify whether or not the oxidized iron was mineralized within the 
hybrid ferroxidase, the iron content of the purified ferritin after the catalytic 
reaction was determined. The combination of Pt-nanoparticles and L-type 
chains showed the most efficient iron mineralization among the samples with 
more than 2000 iron ions per apoferritin on average (Figure 4.5). Pt-huFH 
showed second best values, even higher than recombinant apo-huFH. 
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Figure 4.5. Quantification of mineralized iron in the protein after the mineralization 
reaction by XO. 
 
In agreement with already published data, the ferroxidase activity of apo-
huFH was strongly inhibited in presence of 10 mM Zn2+ (Figure 4.3). With 
Zn2+ the iron oxidation with apo-huFH turned non-enzymatic, similar to the 
case of the ferroxidase inactive apo-huFL. An occupation of the active site of 
the enzyme by Zn2+ may be the reason for the inhibition. This is rather unlikely 
to occur with nanoparticles as active sites.  
According to the assay, Zn2+ slightly lowers the ferroxidase activity of Pt-huFL 
by around 10%, but does not change the manner of the iron conversion 
course. A similar effect was observed with Pt-huFH (Figure 4.6), which 
confirms that the different catalytic mechanism of Pt nanoparticles compared 
to enzymes induces inhibition resistance for Zn2+. The small decrease of iron 
mineralization caused by Zn2+ may be due to a competitive transport of the 
two types of metal ions through the protein channels of apoferritin.  
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Figure 4.6. Inhibitory effect of 10 mM Zn2+ on the ferroxidase activity of Pt-huFH. 
 
During the ferroxidation in mammalian apoferritins 136,137 evolution of H2O2 
was observed. This can cause damage to ferritin in a deregulated cellular 
environment. The stabilities of the proteins were tested by treating 
recombinant L and H apoferritins and Pt-huFL compounds with H2O2 and 
Fe2+. The native gel containing untreated and treated proteins confirms that 
H2O2 itself did not affect the electrophoretic mobility and band intensity of the 
apoferritins and Pt-huFL (Figure 4.7).  
 
 
Figure 4.7. SDS-PAGE of recombinant apo-huFL, apo-huFH and Pt-huFL after 
treatment with 50 mM H2O2 and/or 500 mM Fe2+ for 30 min. M: protein weight 
marker. 
 
However, apo-huFL or apo-huFH proteins completely degraded in 
simultaneous presence of both Fe2+ and H2O2 (Figure 4.7). A further 
observation that ferritin with a ferrihydrite core was degraded upon the 
treatment indicates the key role of iron (Figure 4.8). Apparently, the ferrous 
iron stimulated the degradation of apoferritin, regardless of its ferroxidase 
activity. An exception is seen with Pt-huFL. Identical treatment of Pt-huFL did 
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not result in protein degradation. The stabilization results from the Pt-
nanoparticles being catalase and superoxide dismutase (SOD) active as 
described in the previous chapter. Such parallel activity efficiently detoxifies 
the harmful reactive oxygen species (ROS) evolving during the iron 
metabolism82,95. 
 
 
Figure 4.8. SDS-PAGE of native horse spleen ferritin (hoSF), recombinant human L 
and H apoferritin (apo-huFL and apo-huFH), and Pt-huFL after treatment with 
100 mM H2O2. M: protein weight marker. 
 
Resulting from those experiments, it can be stated that Pt nanoparticles as 
catalytically active sites enhance the ferroxidase activity, stability and the 
mineralization ability of apoferritin. Pt nanoparticles are resistant to the natural 
ferroxidase inhibitor Zn2+, increase the resistant of the protein against ROS 
produced during the iron metabolism and improve the mineralization ability of 
apoferritin. 
4.2 Bioactive Bioinorganic ferroxidase 
Under natural circumstances, the human body already utilizes endogenous 
ferritin both as an antioxidant and for iron depletion 138,139. It is expected that 
our bioinorganic ferroxidase nanozyme, especially the most active Pt-huFL, 
could actively influence the cellular iron level.  
Normally, the cells cannot distinguish apoferritin (iron free) from ferritin (iron 
containing), which opens the possibility to trick the cells in an "iron-rich" 
delusion by incorporating Pt. In vitro tests demonstrate that deferoxamine 
(DFO), an iron-depletion drug, exhibits an iron-depletion effect on human 
intestinal Caco-2 cells, but not on human liver HepG2 cells (Figure 4.9 and 
Figure 4.10).  
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Figure 4.9. Cellular iron content of Caco-2 cells after treatment with deferoxamine 
(DFO, 300 mM), apo- and Pt-huFL (50 mg ml-1), for 24 h. The values are presented 
by mean ± SD. *: p < 0.001. 
 
The synthesized bioinorganic ferroxidase Pt-huFL depleted iron in both types 
of cells (Figure 4.9 and Figure 4.10). Furthermore, the ferritin composites did 
not inhibit the cellular iron uptake in the way DFO does when an excess of 
iron is supplemented (Figure 4.11). In such circumstances, apoferritin 
apparently acts as an iron sponge and a container for intracellular storage.  
 
 
Figure 4.10. Cellular iron content in HepG2 cells after treatment with deferoxamine 
(DFO, 300 µM), apo- or Pt-huFL (50 µg/ml) for 24 h. The values are presented by 
mean ± SD. **: p < 0.001. 
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Figure 4.11. Cellular iron content in Caco-2 cells after the iron challenging with 40 µM 
Fe2+ together with 300 µM DFO , apo- or Pt-huFL (50 µg/ml) for 24 h. The values are 
presented by mean ± SD. *: p < 0.05. 
 
In presence of Zn2+, which also competitively inhibits the cellular iron 
uptake 140, the composites with ferroxidase activity stabilize the intracellular 
iron level (Figure 4.12). It seems that the ferroxidase activity of apoferritin 
plays a role in the cellular response to Zn2+-induced inhibition. The significant 
difference between the ferroxidase active Pt-huFL and inactive apo-huFL 
indicates that the encapsulated ferroxidase-mimetic Pt nanoparticles facilitate 
a stabilizing effect of Pt-huFL on the intracellular iron. This observation also 
verifies the resistance of Pt-containing ferritin to the Zn2+-induced inhibition in 
a cellular environment.  
 
 
Figure 4.12. Cellular iron content in Caco-2 cells after treatment with deferoxamine 
(DFO, 300 mM), apo- and Pt-huFL (50 mg/ml), in presence of 40 mM Zn2+. Untreated 
cells were used as internal control (contr.). The values are presented as mean SD.  
*p < 0.001.  
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In the introduction it was mentioned that the transferrin receptor (TfR) is a 
protein, which takes part in the iron uptake of a cell. In contrast, ferroportin is 
important for the iron release and an essential component in duodenal cells, 
which demark the critical first step the iron uptake of an organism.  
Alterations in the cellular iron uptake through the transferrin receptor (TfR) 
and its export through ferroportin will directly influence the cellular iron 
content 53,55. To address the mechanism of iron-regulation effects of Pt-huFL, 
the translational changes of TfR and ferroportin in Caco-2 and HepG2 cells 
were investigated upon treatment with DFO, apo-huFL or Pt-huFL. DFO had 
no effect on neither of the two iron transporters in Caco-2 and HepG2 cells 
(Figure 4.13). In contrast, Pt-huFL and apo-huFL increased the amount of TfR 
in the membranes of Caco-2 cells. Upon treatment with Pt-huFL an obvious 
increase of the intensity of the ferroportin band was observed in HepG2 cells. 
In contrast to the sole iron-depleting function of DFO, the ferritin-based 
composites influence the cellular iron apparently in a more biological and 
physiological way.  
 
 
Figure 4.13. Western analysis of the transferrin receptor (TfR) and ferroportin 
amounts in the cell membrane fractions upon treatment with DFO, apo-huFL or Pt-
huFL. ATPase was detected as the loading control.  
 
4.3 Summary 
In conclusion, the designed Pt nanoparticles encapsulated within apoferritin 
act as inhibitor-resistant bioinorganic ferroxidase and influence the cellular 
iron homeostasis. The hybrid nature of the engineered enzyme enables its 
cellular iron regulation in a physiologically favorable way, making beneficial 
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use of both the inorganic and biological constituents. The demonstrated 
possibility to use inorganic nanomaterials for fabrication of artificial enzymes 
shows new insights with great promise for enzyme design for future 
biomedical applications.   
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Chapter 5 
Intrinsic properties of ferritin 
The first part of this chapter describes a specific function of the L-chain 
protein, which was discovered upon investigation of the catalytic activity of 
homopolymeric L- and H-chain apoferritins. A redox reaction was designed 
with decoupled reduction and oxidation reactions, which were spatially 
separated by apoferritin proteins. While oxidized cytochrome c (Cyt-c) was 
used as electron acceptor under anaerobic conditions outside the apoferritin 
sphere, an iron oxidation inside the cavity should donate the electrons for the 
reduction. Neither homopolymeric human L- nor H-chain apoferritin (apo-huFL 
and apo-huFH) enabled a redox reaction. Heteropolymeric apoferritin, 
however, promoted the reaction demonstrating distinct functionality of the two 
different subunits. More detailed investigations of the mechanisms revealed 
that the H-chain protein serves as the electron source by catalyzing the iron 
oxidation inside the cavity, while the presence of the L-chain proteins allows 
for an electron transfer across the protein shell of ferritin, promoting the 
reduction of Cyt-c outside the cavity.  
Besides, an extended analysis of the ferritin demineralization process was 
done. Special attention was paid to each type of the subunits of ferritin and 
their demineralization activity upon illumination with light or application of 
reduction agents. The demineralization was coupled with the Cyt-c reduction 
reaction. Finally, the effect of light on the cellular iron metabolism was 
investigated in order to gain more insight into the activity of ferritin. 
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The work described in the first part of the present chapter is published in the 
journal Chemical Communications from the Royal Society of Chemistry 
(RSC). Graphs, figures and parts of the text are reused with permission of the 
publisher 141. 
Article:  
Ferritin light-chain subunits: key elements for the electron transfer across the 
protein cage. U. Carmona, L. Li, L. Zhang and M. Knez. Chemical 
Communications. (2014), 50, 15358-15361 
 
Schematic overview of the investigated reactions  
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5.1 The ferritin L-chain: key element for electron transport 
In the earlier chapters ferritin was described as a suitable template for the 
synthesis of various nanoparticles, enabling a wide range of possible catalytic 
reactions. This range of catalytic activities may be further expanded 
considering that the encapsulating protein can add value to the reactivity of 
the synthetized hybrid compounds. Until now, only little attention was paid to 
the possible occurrence of such synergies. Therefore, a closer look to the 
intrinsic properties of ferritin is needed. 
In vivo, the cytosolic ferritin has a tissue-specific ratio of H:L-chain proteins. 
The sole presence of L-chain protein in ferritin increases the stability and the 
iron mineralization ability of ferritin 136,142, but an increased fraction of the L-
chain protein lowers the crystallization tendency of the mineral inside the 
cavity143. However, detailed understanding about the function of the L-chain 
proteins within the mineralization process is still lacking 144. Although a 
catalytic activity is not identified, the L-chain protein appears to have 
important and specific biological roles, since all ferritin gene disorders 
identified so far involve the L-chain, but not the H-chain ferritin.  
Initially, the intrinsic ferroxidase activity was evaluated for the recombinant 
apo-huFL or apo-huFH homopolymers and apo-hoSF. Since ferritin with its 
oxidized iron incorporated has a characteristic broad absorption peak with a 
maximum at 246 nm, the iron oxidation and the mineral formation was 
followed by UV-vis spectroscopy 134,135. The recombinant apo-huFH has 
ferroxidase-active sites on each subunit, thus the apo-huFH expectedly 
showed a high ferroxidase activity (Figure 5.1). No ferroxidase activity was 
observed for apo-huFL, which was also expected, since the L-chains do not 
contain ferroxidase active sites. For comparison, we measured also the iron-
oxidation activity of purified natural horse spleen apoferritin (apo-hoSF). Apo-
hoSF is a heteropolymeric and L-chain rich apoferritin with 5-10 % H-chain 
content. With only 1 or 2 ferroxidase-active H-subunits per molecule, apo-
hoSF showed a moderate ferroxidase activity. It oxidized iron gradually with 
much slower velocity than the pure H-chain apoferritin.  
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In aerobic conditions, the oxygen molecule acts as electron acceptor during 
iron oxidation and becomes reduced to water. Oxygen can easily reach the 
inner cavity and become reduced on-site with Fe2+ being oxidized. While 
oxygen can enter the cavity, many acceptor molecules may not be able or in 
need to enter the cavity of apoferritin. Cyt-c is a small heme protein and an 
important participant in the electron transport chain in mitochondria. With a 
molecular weight of around 12 kDa it is too large to pass through the channels 
of apoferritin and in this way enter the cavity. Since both oxidized and reduced 
Cyt-c show characteristic UV-vis absorption peaks, the absorption at 550 nm 
is well suitable to characterize the reduction reaction and was thus used in 
this study (Figure 5.2) 97,145. 
 
 
 Figure 5.1. Ferroxidase activity characterized by UV-Vis spectroscopy. The reaction 
was carried out during 5 min with 0.15 mg/ml protein (apo-hoSF: horse spleen 
apoferritin; apo-huFH; apo-huFL. The arrows indicate the evolution of the peak 
characteristic for the iron oxidation. 
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Figure 5.2. Cyt-c reduction activity measured with UV-Vis spectroscopy. The solution 
contained 0.15 mg/ml protein (apo-hoSF: horse spleen apoferritin; apo-huFH: human 
H-chain apoferritin and apo-huFL: human L-chain apoferritin), 10 µM oxidized Cyt-c, 
10 mM Tris-HCl buffer at pH 7.0 and 50 µM (NH4)2Fe(SO4)2. Arrows indicate the 
evolution in the main peaks (orange: iron oxidation; green: main characteristic peak 
of Cyt-c; blue: reduced form of Cyt-c) 
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The reduction of Cyt-c was tracked by following the changes of the 
characteristic absorption peak at 550 nm and extracting the reaction kinetics 
(Figure 5.3). The reaction was set up for running in a non-oxidative 
environment. During the initial 90 s a quasi plateau is seen, which was used 
as reference value (100 % of oxidized Cyt-c). After 90 s the Fe2+ containing 
solution was added and after further 30 s the absorption spectrum was 
measured. After this measurement, the reaction kinetics was measured by 
acquiring absorption spectra in steps of 15 s.  
 
 
Figure 5.3. Reaction kinetics of the Cyt-c reduction. Formation of the reduced Cyt-c 
was followed by measuring the absorbance at 550 nm. The solution contained 
0.30 mg/ml protein, 10 mM Tris-HCl buffer at pH 7.0, 10 µM Cyt-c and 50 µM 
(NH4)2Fe(SO4)2. 
 
In agreement with previously published results, apo-hoSF catalyzed the redox 
reaction of Cyt-c with Fe2+ under anaerobic conditions (Figure 5.4). The 
increasing absorption between 250-300 nm shows the evolution of oxidized 
with progressing iron oxidation during the Cyt-c reduction (Figure 5.2). As 
expected, the reduction of Cyt-c was much slower with the homopolymeric 
ferroxidase-inactive apo-huFL (Figure 5.4). Surprisingly, however, the strongly 
ferroxidase-active apo-huFH also did not yield reduced Cyt-c. Its activity was 
similar to that of the bovine serum albumin (BSA) protein, which served as the 
negative control. 
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Figure 5.4. Formation of reduced Cyt-c from changes in the characteristic absorption 
at 550 nm over time. The reaction was carried out with 0.30 mg/ml protein, 10 µM 
oxidized Cyt-c and 50 µM Fe2+.  
 
In order to confirm that the different activities of the three types of apoferritin 
were due to the distinct properties of the two involved types of subunits, the 
possibility that the observed Cyt-c reduction was caused by superoxide had to 
be ruled out. Superoxide may be produced during the apoferritin-catalyzed 
iron oxidation and could affect the redox reaction 146,147.  
The use of Dojindo`s tetrazolium salt as indicator confirmed that no 
superoxide is formed during the anaerobic iron oxidation under our 
experimental conditions 148. This was further confirmed by following the 
kinetics of the apo-hoSF-catalyzed Cyt-c reduction with addition of superoxide 
dismutase (SOD), which efficiently inhibits the superoxide-induced reduction 
of Cyt-c146. The reduction of Cyt-c by apo-hoSF was not inhibited in presence 
of SOD (Figure 5.5), confirming that superoxide was not involved in the Cyt-c 
reduction in our experiments. Therefore, the L- and H-chains obviously play 
distinct roles in the electron transfer chain between iron and Cyt-c.  
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Figure 5.5. Cyt-c reduction with apo-hoSF with or without addition of 10 µg/ml 
superoxide dismutase (SOD). 
 
The stronger activity of the heteropolymeric apo-hoSF in the Cyt-c reduction 
reaction compared to that of the homopolymeric apoferritin implies that only 
the combination of the two types of protein subunits makes the assembled 
apoferritin seriously active. The involved reaction pathway can be 
simplistically seen as: 1) the oxidation of Fe2+ to Fe3+; 2) the transport of the 
electrons from iron across the protein shell and reduction of Cyt-c. The 
inability of apo-huFH to reduce Cyt-c indicates that the H-chain protein, 
having ferroxidase activity, can carry out the first step only. Thus it can be 
assumed that the L-chain proteins in the heteropolymer are responsible for 
the electron transfer.  
In order to verify this assumption, homopolymeric apo-huFL and apo-huFH 
were disassembled and again reassembled in distinct proportions following 
the previously described method144. In this way a variety of heteropolymeric 
apoferritins containing 10, 50 and 90 % L-chain proteins on the average was 
obtained. Figure 5.6 shows the measured Cyt-c reduction activities of these 
new heteropolymeric apoferritins given as the percentage of reduced Cyt-c 
after 30 s reaction time. Upon increased percentage of L-chain proteins in the 
apoferritin molecules, the activity increased considerably. The heteropolymer 
with 50 % L-chain proteins had a six-fold higher activity in comparison to the 
H-chain homopolymer. An 18-fold increase was achieved once the apoferritin 
contained 90 % L-chain proteins, which roughly corresponds to the mixture in 
Chapter 5 Intrinsic properties of ferritin 
	   85 
the natural heteropolymeric apo-hoSF. Note that the activity enhancement 
could only be achieved with variation of the L:H proportion within the 
heteropolymer. A simple coexistence of H- and L- homopolymers in a 1:9 ratio 
in the solution did not yield any activity increase (Figure 5.6). Thus, the 
utilized apoferritin needs to contain L-chain proteins to transfer the electrons 
evolving during the iron oxidation at the H-chain protein. 
 
 
Figure 5.6. Percentage of reduced cytochrome c (Cyt-c) after 30 s of reaction time 
with 0.15 mg/ml protein (H- or L-chain apoferritin (apo-H or apo-L) and 
heteropolymeric apoferritin with the indicated L-chain protein content). 10 µM 
oxidized Cyt-c was added to the reaction solution.  
 
 
Figure 5.7. Comparison of the Cyt-c reduction by human L-chain apoferritin (apo-
huFL) with or without Pt nanoparticles within its cavity (Pt-huFL).  
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The question occurs whether or not the interactions between H- and L-chain 
proteins are necessary for the electron transport. To confirm that the L-chain 
proteins are the only responsible unit for the electron transfer, it was 
necessary to find a substitute for the H-chain proteins as the electron source. 
Pt nanoparticles synthesized within apoferritin can act as active sites for the 
Fe2+ oxidation reaction, which was already described in the previous 
chapter 127. Once synthesized within L-chain apoferritin, such artificial 
ferroxidases should make the H-chain proteins obsolete. We evaluated the 
activity of such L-chain apoferritins with Pt nanoparticles embedded in their 
cavity (Pt-huFL) for the reduction of Cyt-c. Indeed, the Pt-huFL was 
catalytically active (Figure 5.7) demonstrating that the H-chain proteins are 
not required for the electron transfer. The electron transfer is a specific 
property of the L-chain proteins. 
 
 
Figure 5.8. Upper spectra: Ferroxidase activity of horse spleen apoferritin (apo-hoSF) 
characterized with UV-Vis spectroscopy. The solution contained 0.15 mg/ml protein, 
10 mM Tris-HCl buffer at pH 7.0 and 50 µM (NH4)2Fe(SO4)2. Lower spectra: Cyt-c 
reduction activity of apo-hoSF characterized with UV-Vis spectroscopy. The solution 
contained 0.15 mg/ml protein, 10 µM Cyt-c, 10 mM Tris-HCl buffer at pH 7.0 and 
50 µM (NH4)2Fe(SO4)2. Arrows indicate the evolution of the peaks characteristic of 
the iron oxidation.  
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The Cyt-c reduction provides the evidence of outward electron transport from 
the interior iron oxidation site and facilitates the iron mineralization within 
ferritin (Figure 5.8). In natural circumstances this may be important for the 
newly synthesized apoferritin to mineralize and store excess iron. Even upon 
iron oxidation under aerobic conditions, the possibility for the electrons to be 
transferred across the protein shell may speed up the reaction while 
circumventing the rate determining step, the diffusion of reactants such as O2 
into the ferritin cavity 62. But for the mineral containing ferritin the reverse 
electron transport was necessary in order to reduce the interior Fe3+ and 
demineralize iron where needed.  
5.2 Ferritin demineralization 
In order to verify whether or not the electron transport through the L-chain 
protein is bi-directional, NADH/FMN was used as electron donor for a 
demineralization of ferritin 149. We compared the demineralization of the 
human homopolymeric L- and H-chain ferritin with a similar iron mineral 
content.  
 
 
Figure 5.9. Comparison of the demineralization rate of natural horse spleen ferritin 
(hoSF), and recombinant human L- and H-ferritin (huFL and huFH). 
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As shown in Figure 5.9, the demineralization of horse spleen ferritin started 
more rapidly than that of huFL and huFH, but the release speed was slower 
than in the case of the recombinant L-chain homopolymer. The 
demineralization of L-chain ferritin started earlier and was faster than that of 
H-chain ferritin. Since NADH/FMN molecules are too large to enter the ferritin 
cavity, the reduction of the ferritin mineral through a direct contact with the 
reducing agent was avoided. The differences in the reaction velocity reflect 
serious differences in the electron transportability between the L- and H-chain 
proteins and consequently the demineralization of ferritin. 
The ferritin L-chain protein can transport an electron through the protein shell 
in both directions 141. From that perspective, the iron oxidation, which was 
facilitated with assistance of L-chain proteins, could also be inverted to a 
reduction of the mineral. This may be possible by applying chemistry or 
electromagnetic radiation, for example, light. 
5.3 Light-induced demineralization 
In previous studies it was proposed that the ferrihydrite core in ferritin may act 
as photocatalyst for redox reactions 150–152. Such effect may result from the 
fact that the mineral is a semiconductor and able to generate an electron-hole 
pair upon irradiation with UV-vis light. The UV-Vis irradiation generates a 
catalyst for the redox reaction 153, but also a side effect: it can also act as a 
photocorrosive degrading the mineral itself 154.  
The degradation of the iron mineral within ferritin and the release of iron from 
ferritin was studied in order to estimate the amount and availability of iron. For 
this purpose, light sources with various wavelengths were applied. Light 
emitting diodes (LEDs) were chosen, since they emit in well-defined 
wavelengths. Four colors, blue, green, yellow and red were used for the 
demineralization of horse spleen ferritin (Figure 10).  
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Figure 5.10. Demineralization of horse spleen ferritin (hoSF) upon irradiation with 
blue, green, yellow or red LEDs. 
 
The curves in Figure 5.10 show that only the most energetic, blue light is able 
to reduce the ferritin mineral, while the green, yellow or red LEDs even after 
30 min of irradiation had no effect on the iron. For identifying the optimal 
testing conditions, the light-induced reaction with horse Spleen Ferritin was 
further analyzed in presence of various buffers. 
 
Figure 5.11. Demineralization of hoSF was quantified by measuring the complex of 
released iron with ferene S in presence of various buffers and pH values as indicated 
in the legend.  
Chapter 5 Intrinsic properties of ferritin 
 90	  
Figure 5.11 shows that in acidic conditions the release of iron from ferritin was 
much faster than in neutral or basic conditions, with one exception: in 
presence of HEPES buffer with a pH close to the physiological pH, the 
release of iron was faster than expected. HEPES buffer may potentially react 
with iron 155. Due to this potential reactivity it was considered not being 
suitable for the further reactions.  
Tris buffer-stabilized mineral reduction and release from ferritin can be more 
easily controlled over time due to the rather slow release kinetics. 
Furthermore, the pH is close to physiological conditions, which is optimal for 
the Cyt-c reduction. Therefore, Tris buffer with pH 7 was considered as the 
most appropriate buffer for the following experiments. 
 
 
Figure 5.12. Demineralization of three different types of ferritin, horse spleen ferritin 
(hoSF), human H-chain ferritin (huFH) and human L-chain ferritin (huFL), quantified 
by measuring the complex of ferene S with the released iron. 
 
With the defined buffer (Tris) and light source (blue LED), the demineralization 
of iron in horse spleen ferritin and human L- and H-chain ferritins was 
quantified by measuring the concentration of the complex of Ferene S with the 
released Fe2+ ions over time (Figure 5.12). It was found that the two ferritins 
that contain ferroxidase activity show a faster release of iron in comparison to 
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human L-chain ferritin that lacks such activity. Obviously, the ferroxidase 
activity is of importance for the demineralization. In order to verify this, an 
analogous experiment with the mineral without the surrounding protein was 
performed.  
For this purpose, in advance of the demineralization reaction, proteinase K 
was used for the digestion of the protein shell of ferritin. This should facilitate 
the direct contact of the iron mineral with ferene S. The mineral was exposed 
directly to the light and reduced. The reduced iron was immediately 
complexed by Ferene S. This procedure allows analyzing the contribution of 
the ferritin shell to the process and at the same time confirming the degrading 
effect of the light on the ferritin mineral.  
Figure 5.13 shows the demineralization kinetics for each of the utilized ferritin 
minerals. From the demineralization kinetics two differences can be seen after 
comparison with the experiment that included the protein (Figure 5.12). 
 
 
Figure 5.13. Demineralization of the minerals obtained from three different ferritins 
after digestion of the protein with Proteinase K (Pr-K), quantified by measuring the 
complex of reduced iron with Ferene S: horse spleen ferritin (hoSF); human H-chain 
ferritin (huFH) and human L-chain ferritin (huFL). 
The first observable difference is that with the bare mineral the reduction of 
iron started immediately with the reaction. The second observable difference 
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is that the minerals formed by ferroxidase (hoSF and huFH) were more 
quickly reduced than the minerals initially formed within the homopolymeric L-
chain apoferritin. Obviously, the mineral formed within L-chain ferritin is of 
slightly different nature than that in the other two cases. However, the 
difference between those minerals is minor and may not be of critical 
importance for the further experiments.  
In the following experiments L- and H-ferritin in their natural form were used. 
In the experiments until now, the demineralization process induced by the 
blue light was characterized by chelating the liberated iron with ferene S. 
Without any chelating agent the reduced iron would be available to act as a 
reducing agent for a subsequent redox reaction. In contact with Cyt-c, iron 
may become oxidized while reducing Cyt-c.  
Blue light is able to reduce the mineral but not Cyt-c. This was confirmed by 
exposing Cyt-c to blue light and characterizing the reaction kinetics 
(Figure 5.14). The characteristic absorption peak of the reduced form of Cyt-c 
at 550 nm was used to follow the reaction kinetics. 
 
 
Figure 5.14. Formation of reduced Cyt-c measured from changes in the absorption at 
550 nm over time. The reaction was carried out with 0.15 mg/ml protein as indicated 
in the legend, 10 µM oxidized Cyt-c and illumination with blue LED light. 
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Horse spleen ferritin showed best efficiency for reducing Cyt-c among all 
tested ferritins. Apparently the simultaneous presence of both L- and H-chain 
protein in hoSF is beneficial for reducing the mineral with light.  
The light-induced reduction of Cyt-c by human L- and H-chain ferritins was 
considerably less efficient. Among the two ferritins, the L-chain ferritin had a 
slightly higher activity than the H-chain ferritin. This can be explained with the 
electron transport ability of L-chain proteins. Once the iron becomes oxidized, 
the L-chain will transport the electron across the protein shell to reduce the 
Cyt-c at the outer surface of the protein shell.  
In contrast, H-chain ferritin did not show any evidence for electron transport 
properties, which would be needed to reduce the Cyt-c outside the shell in 
Figure 5.4. However, the Cyt-c reduction in Figure 5.14 shows similar activity 
to the L-chain ferritin. The reason may potentially lie in the reactive oxidative 
compounds that form during the reduction and re-oxidation of the iron of the 
mineral. 
5.4 Cell culture 
The previous section showed that blue light enables the reduction of the 
ferrihydrite mineral of ferritin. The reduced iron can be released from the 
protein structure and can be involved into a secondary reaction to reduce 
another electron acceptor. Those experimental results imply that in a 
biological environment light can be used to alter the cellular iron metabolism. 
Thus, the previously described experiments were translated to cell cultures. 
For the experiments with cell cultures a setup was built, which allowed to 
conserve the most important cell conditions during the experiments: 
temperature, gas flow, atmosphere and sterile environment. The setup 
consists of a box with an open lateral wall were the cells can be loaded or 
removed. Holes in the upper part allow a better heat dissipation and 
temperature uniformity. All the parts or components can be easily 
disassembled and sterilized with ethanol or propanol and by UV irradiation. 
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Figure 5.15 shows a photograph of the setup with a 96 well plate for the cell 
cultures. 
 
 
Figure 5.15. Photograph of the setup for the treatment of cells by irradiation with blue 
light. 
 
Initially, the viability of the cells was quantified by comparing the survival rate 
of light-exposed cells to that of control cells, which did not undergo any 
treatment. Considering the value of the absorption obtained from the cell 
counting kit 8 (CCK8) for control cells being 100 %, the viability of the light-
exposed cells was calculated from their absorption values (Figure 5.16). The 
cells were irradiated with blue light for 24, 48 and 72 h.  
Two interesting observations can be made from Figure 5.16. On the one 
hand, upon shorter irradiation the viability of irradiated cells is higher than that 
of the control cells, although not significantly. On the other hand, extended 
irradiation induces the opposite effect. After 48 and 72 h exposure to blue 
light, the viability of the cells decreased seriously by in 20 and 40 %, 
respectively.  
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Figure 5.16. Cell viability values obtained from the Cell Counting Kit 8 (CCK-8). Red 
bars show the reference values of the control cells (C) and blue bars the 
corresponding values of cells irradiated with blue light (L). The exposure to blue light 
lasted for 24; 48 and 72 h. 
 
The initial increase in viability points towards an initial enhancement of the 
cellular activity induced by the excess of free and available iron. However, 
prolonged exposure to light may induce the formation of ROS as result of the 
excess available Fe2+ and in this way lower the cell viability. 
Light reduces the iron from the ferritin mineral and makes it available for the 
cells. In presence of excess iron, the cells tend to store it and save it for later 
use. The abundance of Fe2+ will require a higher production of H-chain 
apoferritin to decrease the Fe2+ levels and avoid the ROS production and 
oxidative stress. Therefore, the western blotting technique was applied to 
analyze the amount of H-chain subunits in irradiation-treated cells and control 
cells (Figure 5.17). 
 
 
Figure 5.17. Western blot of Caco-2 cells anti-huFH and anti-actin as a protein 
loading control. Control (C) and treated (T) cells after exposure to blue light for 24, 48 
and 72 h. 
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The western test clearly shows a decrease in the amount of human H-chain 
ferritin detected in the cells after exposure to light. After 24 h, no significant 
difference to the control cells is seen, but after extension to 48 and 72 h, the 
difference in the content of H-chain subunits in treated and control cells 
became apparent. In normal conditions, the amount of H-chain proteins will 
increase over time. Both the control and treated cells confirm this trend, but 
with a great difference in quantity.  
Upon demineralization and enhanced release of Fe2+, the cells should 
respond with enhanced production of H-chain proteins, which is not observed. 
On the contrary, the amount of the H-chain protein is decreasing with 
extended exposure to light. Thus, a possible damage caused by excess Fe2+ 
can be assumed. Most likely the larger amount of released iron caused an 
enhanced production of ROS. Those species will cause oxidative stress in the 
cells, negatively affecting the cellular metabolism. This can be a crucial factor 
for the decrease of the cell viability.  
An observation related to that, but from a different perspective, was recently 
published by Nakashima Y. et al 156. In their work, an enhanced ROS 
production induced by blue light is claimed to promote skin aging. 
Mitochondria are considered to be the responsible production sites of the 
damaging ROS, although further details were not investigated or disclosed. 
Mitochondria also contain ferritin, the mitochondrial ferritin, which may be the 
original source for the iron as catalyst for the ROS production, giving rise to 
the speculation that the work of Nakashima Y. et al. and the present 
investigation have some relation to each other. 
5.5 Summary 
The initial experiments in this chapter show that the electron transport is a 
specific function of the L-chain protein of ferritin and the first identified function 
of this type of protein. The results are of great importance and seriously 
contribute to the understanding of the biological functions of the L-chain in 
ferritin. Two protein subunits with distinct and complementary functionality 
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provide organisms flexibility for organ-specific adjustments of ferritin to meet 
the varying requirements and supply of iron. As shown in the aforementioned 
results, the iron mineralization capacity of ferritin can be adjusted simply by 
changing the ratio of the two subunits within the molecule. This may be one 
important reason for the co-existence of the ferroxidase-inactive L-chain 
protein and the ferroxidase-active H-chain proteins in mammals. In this light, 
the previously described observation of only few L-chain proteins being 
sufficient for altering the capacity of the ferritin for iron incorporation becomes 
meaningful 136,142. 
The electron transport across the protein shell as a specific functionality of the 
L-chain protein was another piece of the puzzle for understanding the 
biological and medical significance of the ferritin subunits. The biological role 
of this protein seems to be important, since a decreased L-chain level or L/H-
ratio has been observed in Parkinson's and Alzheimer diseases 157. However, 
further and more detailed investigations of the transfer mechanism through 
the L-chain will be needed from the biochemical and biotechnical 
perspectives 158. 
A bidirectional electron transport was demonstrated with the demineralization 
of the ferritin mineral by applying reducing agents. Electron donor molecules 
were used to reduce the iron in the mineral and release it from the ferritin 
cavity.  
By selecting large reducing agents, a diffusion of those molecules into the 
ferritin cavity was hindered and the electron transport through the protein 
enforced. Another way for demineralization of the core uses irradiation with 
light. The effect of irradiation of ferritin with blue light was investigated in detail 
with a variety of ferritin types. 
Finally, the effect of the blue light on cells was investigated, which resulted in 
an initial enhancement of the cell viability after the first 24 h of illumination and 
a significant decrease in viability after 48-72 h. 
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Chapter 6 
Conclusions and Future work 
In this thesis, the enzyme mimetic activities of natural ferritin and synthetic 
ferritin-based hybrid compounds were investigated. The three main parts 
(chapters 3, 4 and 5) of the thesis showed different approaches towards 
studying the properties from different perspectives. In chapter 3 the catalytic 
properties were in focus, describing the encapsulation of nanoparticles, their 
catalytic activity and the inhibition of catalytic reactions. Chapter 4 was related 
to biomineralization, investigating the ferroxidase activity of the hybrid 
compounds and their application in cell cultures. The focus of chapter 5 was 
on the intrinsic properties of the ferritin proteins, specifically the intrinsic 
properties of the L-chain protein. 
In the fist part platinum nanoparticles were grown within ferritin (Pt-apo) and 
the resulting hybrid composite and its stability was confirmed by native gel 
and TEM and UV-Vis spectroscopy. The catalase and SOD mimicking 
activities of the hybrid compound were investigated with and without presence 
of inhibitors. It was found that NaN3 could inhibit the catalase activity of Pt-
apo, but not the SOD activity. In contrast, 3AT was able to inhibit both 
reactions. This knowledge enables to selectively inhibit one reaction without 
affecting the other. Furthermore, the inhibited activities can be recovered 
simply with the use of reducing agents, which will recover the nanoparticle 
surface. This was proven by XPS. This process can be adapted to further 
nanoparticles, which opens the possibility to detoxify intoxicated catalytic 
surfaces. 
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In close relation to the mentioned catalytic activity, in the second part the 
catalase activity of gold nanoparticles in presence of Hg2+ ions was 
investigated. It was found that mercury could activate the otherwise not 
present catalase activity of Au-apo or Au nanoparticles. Further experiments 
with Au films showed that mercury interacts with the gold surface, making the 
hydrogen peroxide decomposition reaction possible. An explanation based on 
a reduction of Hg2+ was postulated. Most likely Hg2+ becomes reduced Hg+, 
which in presence of Cl- precipitates as Hg2Cl2, but in addition disproportions 
to Hg2+ and Hg0, which with gold forms a catalytically reactive amalgam. 
Besides the catalase and SOD activities, a further activity of Pt-apo, the 
ferroxidase activity, was investigated. Once encapsulated within pure L-chain 
ferritin, which naturally does not show ferroxidase activity, platinum 
nanoparticles induce such activity. The activity and its influence on the iron 
homeostasis after incorporation of the composites into cells were 
characterized. Iron regulation is crucial for life and the possibility to adjust the 
iron regulation with materials that can substitute natural enzymes may have 
great promise for a variety of future therapies.  
The foreseen applications of hybrid bioinorganic nanoparticles in the industrial 
production of chemicals, sensing or biomedical application are directly related 
to their catalytic activity. The possibility to control the activity by inhibitors and 
the recovery of the catalytic activity open a wide range of opportunities for 
industrial or biomedical processes. 
In the last part the properties of the protein shell were investigated. 
Specifically, the intrinsic electron transport ability of the L-chain protein was 
identified, which was never observed before. The characterization was based 
on two spatially separated, but coupled reactions. An iron oxidation was 
performed inside the cavity of ferritin, while a reduction of cytochrome c took 
place outside of the ferritin at the same time. Given that the ferritin shell 
separated the reactions, a proceeding redox reaction is a direct evidence of 
the transport of electrons. While with H-chain proteins only minor reactivity 
was observed, with L-chain ferritin the reduction of Cytochrome c was rapid 
and nearly quantitative. This evidence may induce further research, 
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particularly towards identifying the reason why the two types of proteins are 
present in various tissues and why the ratio between L and H chain proteins in 
the body can vary between various tissues and organs.  
As a last investigation, the impact of light on the demineralization of the 
ferrihydrite mineral inside ferritin was characterized. For this purpose, ferritin 
was illuminated with light of various wavelengths, which showed that the most 
energetic blue light was most efficient for reducing iron from the mineral. 
Resulting from this, it can be inferred that light can interfere into the iron 
homeostasis as well. If transferred to cells, the cell viability will suffer with light 
illumination. The experiments have shown that amount of cells after 48-72 
hours of exposure to blue light was 20-30% less. Although it is not yet clear 
what is the determining factor for the cell death, this study may be a first step 
towards inducing intracellular processes and the starting point for establishing 
novel and controlled light therapies. 
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List of abbreviations 
(3AT) 3-amino-1,2,4-triazole  
(AAS) Atomic Absorption Spectroscopy  
(AFM) Atomic force microscopy 
(apo-hoSF) horse Spleen apoferritin 
(apo-huFH) recombinant human Heavy-chain apoferritin  
(apo-huFL) recombinant human Light-chain apoferritin  
(APP) b-amyloid protein precursor  
(Au-apo) Gold nanoparticle encapsulated within apoferritin 
(Au-huFL) gold nanoparticle encapsulated within L-chain apoferritin 
(BSA) Bovine Serum Albumin  
(CCK-8) Cell Counting Kit-8 
(Cyt-c) Cytochrome C  
(DFO) Deferoxamine  
(DNA) Deoxyribonucleic acid  
(EDX) Energy-dispersive X-ray spectroscopy  
(FBS) Fetal Bovine Serum  
(Ferene S) 3-(2-Pyridyl)-5,6-di(2-furyl)-1,2,4-triazine-5′,5′′-disulfonic acid 
disodium salt  
(FMN) Flavin mononucleotide  
(H-chain) Heavy-chain subunit  
(hoSF) horse Spleen Ferritin 
(huFH) recombinant human Heavy-chain Ferritin 
(huFL) recombinant human Light-chain Ferritin,  
(ICP-MS) Inductively coupled plasma mass spectrometry 
(L-chain) Light-chain subunit  
(LEDs) Light Emitting Diodes  
(MES) 2-(N-morpholino)ethanesulfonic acid 
(MRI) Magnetic Resonance Imaging  
(MWCO) Molecular Weight Cut-Off  
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(NADH) Nicotinamida Adenine dinucleotide 
(kDa) Kilo Dalton  
(KAuCl4) Potassium gold(III) chloride  
(K2PtCl4) Potassium platinum (II) chloride  
(PAGE) Polyacrylamide gel electrophoresis  
(PBS) Phosphate-Buffered Saline  
(PMMA) Poly(methyl methacrylate)  
(Pt-apo) Platinum nanoparticle encapsulated within apoferritin  
(Pt-huFH) Platinum nanoparticle encapsulated within H-chain apoferritin 
(Pt-huFL) Platinum nanoparticle encapsulated within L-chain apoferritin  
(PtAu-apo) Platinium-gold bimetal nanoparticle encapsulated within 
apoferritin  
(PVDF) Polyvinylidene fluoride  
(ROS) Reactive Oxygen Species  
(RSC) Royal Society of Chemistry 
(RT) Room Temperature  
(SD) Standard Desviation 
(SDS-PAGE) Sodium dodecyl sulphate-polyacrylamide gel electrophoresis  
(SEM) Scanning Electron Microscopy 
(SOD) Superoxide Dismutase  
(TBST) 25 mM Tris HCl pH 7.5; 150 mM NaCl; 0.05% Tween 20 
(TEM) Transmission Electron Microscopy 
(TMB) 3, 3´, 5, 5´-tetramethylbenzidine  
(Trf) Transferrin 
(TfR) Transferrin Receptor  
(UV-Vis) Ultraviolet-Visible  
(WST-1) Dojido`s water-soluble tetrazolium salt  
(XO) Xylenol Orange  
(XPS) X-Ray Photoelectron Spectroscopy 
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